Poisons and Narcotic Drugs (Amendment) Act 1988 (ACT)

AUSTRALIAN CAPITAL TERRITORY

Poisons and Narcotic Drugs (Amendment) Ordinance 1988

No. 96 of 1988

I, THE GOVERNOR-GENERAL of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Ordinance under the Seat of Government (Administration) Act 1910.

Dated 15 December 1988

N. M. STEPHEN

Governor-General

By His Excellency’s Command,

CLYDE HOLDING

Minister of State for the Arts

and Territories

An Ordinance to amend the Poisons and Narcotic Drugs Ordinance 1978

Short title

1.  This Ordinance may be cited as the Poisons and Narcotic Drugs (Amendment) Ordinance 1988.1

Commencement

2.  This Ordinance commences on such date as is fixed by the Minister by notice in the Gazette.

Principal Ordinance

3.  In this Ordinance, “Principal Ordinance” means the Poisons and Narcotic Drugs Ordinance 1978.2

Substances to which Division applies

4.  Section 27B of the Principal Ordinance is amended by adding at the end the following paragraphs:

“;(f)  follicle stimulating hormone;

(g)luteinising hormone;

(h) thalidomide.”.

Grant of authorisation

5.  Section 27E of the Principal Ordinance is amended—

(a)by omitting from paragraph (1) (a) “or cyclofenil” and substituting “, cyclofenil, follicle stimulating hormone or luteinising hormone”;

(b)by omitting from paragraph (1) (b) “and”; and

(c)by adding at the end of subsection (1) the following word and paragraph:

“; and (d)in the case of an application that relates to thalidomide—the applicant is a specialist physician with no less than 5 years’ experience in the treatment of erythema nodosum leprosum.”.

Substitution—Schedules

6.  Schedules 1 to 8, inclusive, and Schedule 12, to the Principal Ordinance are repealed and the following schedules respectively substituted:

SCHEDULE 1  Section 3

Aconite (root of Aconitum napellus)

Antimony compounds, except—

(a)when included in Schedule 4; or

(b)antimony chloride in polishes

Atropine, except when included in Schedule 2 or 4

Belladonna, except when included in Schedule 2

Bromine, excluding its salts and derivatives

Brucine, except when used in concentrations of 0.02% or less for the denaturation of alcohol

Comfrey (Symphytum spp) for human internal use, being—

(a)any preparation; or

(b)any part of the dried plant

Coniine

Cotarnine

Croton Oil

Cyanides—see Hydrocyanic Acid

Homatropine, except when included in Schedule 2

Hydrocyanic Acid and Cyanides for therapeutic use, except when included in Schedule 2

Hyoscine, except when included in Schedule 2 or 4

Hyoscyamine, except when included in Schedule 2

Hyoscyamus, except when included in Schedule 2

Lobelia, except—

(a)when included in Schedule 2; or

(b)in preparations for smoking or burning

Lobeline, except—

(a)when included in Schedule 2; or

(b)in preparations for smoking or burning

Mercuric Chloride, except when included in Schedule 2 or 7

Mercuric Iodide, except when included in Schedule 2 or 6

Mercuric Nitrate, except when included in Schedule 2

Mercuric Potassium Iodide, except when included in Schedule 2

Mercuric Thiocyanate, except when included in Schedule 6

Mercury organic compounds, except—

(a)when included in Schedule 2, 4 or 6;

(b)ethoxyethylmercuric chloride and ethylmercuric chloride in Schedule 7; or

(c)in preparations containing 0.01% or less of mercury as a preservative

Nux Vomica

Phosphorus, Yellow (excluding its salts and derivatives), except when included in Schedule 6

Savin, oil of

Stramonium, except—

(a)when included in Schedule 2; or

(b)in preparations for smoking or burning

Tansy, oil of

Veratrum, except when included in Schedule 4

SCHEDULE 2  Section 3

Acetic Acid (excluding its salts and derivatives) in preparations containing more than 80% of acetic acid, for therapeutic use

Aloxiprin

Ammoniated Mercury

Antazoline in eye drops

Aspirin, except—

(a)when included in Schedule 4;

(b)in tablets or capsules each containing 325 mg or less of aspirin as the only therapeutically active constituent, other than an effervescent buffering system, when—

(i)the pack is labelled—

“WARNING—THIS MEDICATION MAY BE DANGEROUS WHEN USED IN LARGE AMOUNTS OR FOR LONG PERIODS”; or

“CAUTION—THIS PREPARATION IS FOR THE RELIEF OF MINOR AND TEMPORARY AILMENTS AND SHOULD BE USED STRICTLY AS DIRECTED. PROLONGED USE WITHOUT MEDICAL SUPERVISION COULD BE HARMFUL”;

(ii)packed in blister or strip packaging or in containers with a child-resistant closure; and

(iii)in a primary pack containing not more than 25 such tablets or capsules; or

(c)in individually wrapped powders or sachets of granules each containing 650 mg or less of aspirin as the only therapeutically active constituent, other than an effervescent buffer, when—

(i)the pack is labelled—

“WARNING—THIS MEDICATION MAY BE DANGEROUS WHEN USED IN LARGE AMOUNTS OR FOR LONG PERIODS”; or

“CAUTION—THIS PREPARATION IS FOR THE RELIEF OF MINOR AND TEMPORARY AILMENTS AND SHOULD BE USED STRICTLY AS DIRECTED. PROLONGED USE WITHOUT MEDICAL SUPERVISION COULD BE HARMFUL”; and

(ii)in a primary pack containing not more than 12 such powders or sachets of granules

Atropine—

(a)in preparations containing 0.25% or less of atropine; or

(b)atropine sulphate, 0.6 mg tablets in packs of six, when labelled for treatment of organophosphorus poisoning;

except atropine methonitrate included in Schedule 4

Belladonna in preparations containing 0.25% or less of the alkaloids of belladonna, calculated as hyoscyamine

Benzamine when included in—

(a)lozenges, pastilles, tablets or capsules containing 30 mg or less of benzamine in each;

(b)suppositories or bougies containing 200 mg or less of benzamine in each; or

(c)preparations for external use, other than eye drops, containing 10% or less of benzamine

Benzocaine when included in—

(a)lozenges, pastilles, tablets or capsules containing 30 mg or less of bezocaine in each;

(b)suppositories or bougies containing 200 mg or less of benzocaine in each; or

(c)preparations for external use, other than eye drops, containing 10% or less of benzocaine

Benzoyl Peroxide in preparations for external human therapeutic use containing 5% or less of benzoyl peroxide

Benzydamine in preparations for topical use containing 3% or less of benzydamine

Bromhexine

Brompheniramine in oral preparations when compounded with one or more of the following medicaments—

(a)an antitussive, except codeine or dihydrocodeine;

(b)an expectorant; or

(c)a sympathomimetic amine;

except in preparations for the treatment of children under 2 years of age

Buclizine in primary packs of 10 doses or less, for the prevention or treatment of motion sickness

Butylaminobenzoate when included in—

(a)lozenges, pastilles, tablets or capsules containing 30 mg or less of butylaminobenzoate in each;

(b)suppositories or bougies containing 200 mg or less of butylaminobenzoate in each; or

(c)preparations for external use, other than eye drops, containing 10% or less of butylaminobenzoate

Carbaryl in preparations for external human therapeutic use containing 2% or less of carbaryl

Carbenoxolone for topical oral use

Carbetapentane, except in preparations containing 0.5% or less of carbetapentane

Chloroform in preparations for therapeutic use, except—

(a)when included in Schedule 4; or

(b)in preparations containing 0.5% or less of chloroform

Chlorpheniramine in oral preparations when compounded with one or more of the following medicaments—

(a)an antitussive, except codeine or dihydrocodeine;

(b)an expectorant; or

(c)a sympathomimetic amine;

except in preparations for the treatment of children under 2 years of age

Cinnamedrine

Clioquinol and other halogenated derivatives of 8-Hydroxyquinoline for external human use

Codeine—

(a)when compounded with aspirin, paracetamol or salicylamide or any one of their derivatives, in tablets or capsules each containing 10 mg or less of codeine, and no other analgesic substance, when—

(i)packed in blister or strip packaging or in containers with child-resistant closures; and

(ii)in a primary pack containing 25 or less dosage units; or

(b)when compounded with one or more other therapeutically active substances—

(i)in divided preparations containing 10 mg or less of codeine per dosage unit and with a recommended dose not exceeding 15 mg of codeine; or

(ii)in undivided preparations containing 0.25% or less of codeine and with a recommended dose not exceeding 15 mg of codeine

Creosote derived from wood, for human therapeutic use, except in preparations containing 3% or less of phenols included in Schedule 2

Cyanides—see Hydrocyanic Acid

DDT—see Dicophane

Dexchlorpheniramine in oral preparations when compounded with one or more of the following medicaments:

(a)an antitussive, except codeine or dihydrocodeine;

(b)an expectorant;

(c)a sympathomimetic amine;

except in preparations for the treatment of children under 2 years of age

Dextromethorphan when compounded with one or more other therapeutically active substances—

(a)in divided preparations containing 30 mg or less of dextromethorphan per dosage unit and with a recommended dose not exceeding 30 mg of dextromethorphan; or

(b)in undivided preparations containing 0.3% or less of dextromethorphan with a recommended dose not exceeding 30 mg of dextromethorphan

trans-4-((3,5-Dibromo-2-hydroxybenzyl)-amino) cyclohexanol hydrochloride monohydrate (Sputolysin) in oral preparations for the treatment of animals

Dicophane (DDT) in preparations for human therapeutic use

Dicyclomine in preparations containing 0.1% or less of dicyclomine

Dihydrocodeine when compounded with aspirin and no other therapeutically active substance, in divided preparations containing 5 mg or less of dihydrocodeine per dosage unit and with a recommended dose not exceeding 10 mg of dihydrocodeine when—

(a)packed in blister or strip packaging or in containers with child-resistant closures; and

(b)in a primary pack containing 25 or less dosage units

Dimenhydrinate in primary packs of 10 doses or less, for the prevention or treatment of motion sickness

Dimethisoquin in preparations for topical use

Diphemanil Methylsulphate in preparations for topical use

Diphenhydramine—

(a)in primary packs of 10 doses or less, for the prevention or treatment of motion sickness; or

(b)in oral preparations when compounded with one or more of the following medicaments:

(i)an antitussive, except codeine or dihydrocodeine;

(ii)an expectorant;

(iii)a sympathomimetic amine;

except in preparations for the treatment of children under 2 years of age

Diphenylpyraline in oral preparations when compounded with one or more of the following medicaments:

(a)an antitussive, except codeine or dihydrocodeine;

(b)an expectorant;

(c)a sympathomimetic amine;

except in preparations for the treatment of children under 2 years of age

Doxylamine in oral preparations when compounded with one or more of the following medicaments:

(a)an antitussive, except codeine or dihydrocodeine;

(b)an expectorant;

(c)a sympathomimetic amine;

except in preparations for the treatment of children under 2 years of age

Ephedrine for internal use, when compounded with one or more other therapeutically active substances in preparations containing 30 mg or less of ephedrine per recommended dose, other than preparations for stimulant, appetite suppression or weight control purposes, except in liquid preparations containing 10 mg or less of ephedrine per recommended dose

Erythrityl Tetranitrate for therapeutic use

Etafedrine

Ether for therapeutic use, except—

(a)when included in Schedule 4; or

(b)in preparations containing 10% or less of ether

Ethoheptazine in preparations containing 1% or less of ethoheptazine

Ethylmorphine when compounded with one or more other therapeutically active substances—

(a)in divided preparations containing 10 mg or less of ethylmorphine per dosage unit and with a recommended dose not exceeding 15 mg of ethylmorphine; or

(b)in undivided preparations containing 0.25% or less of ethylmorphine with a recommended dose not exceeding 15 mg of ethylmorphine

Fluorides for human therapeutic use, being—

(a)sodium fluoride in preparations for ingestion containing 2.2 mg or less of sodium fluoride per dosage unit, except in preparations for the treatment of children under 2 years of age; or

(b)in preparations for topical use, except—

(i)when included in Schedule 3;

(ii)in dentifrices containing 1000 mg/kg or less of fluoride ion; or

(iii)in other substances containing 15 mg/kg or less of fluoride ion

Gelsemium

Glutaraldehyde for human therapeutic use

Glyceryl Trinitrate for therapeutic use, except when included in Schedule 4

Guaiphenesin—

(a)in liquid preparations containing 2% (200 mg/10 ml) or less of guaiphenesin; or

(b)in divided preparations containing 120 mg or less of guaiphenesin per dosage unit

Hexachlorophane in preparations for human skin cleansing purposes containing 3% or less of hexachlorophane, except in preparations for use on infants as specified in Schedule 4

Homatropine in preparations containing 0.25% or less of homatropine

Human Chorionic Gonadotrophin or Antibody in pregnancy test kits

Hydrocyanic Acid and Cyanides in preparations for therapeutic use containing the equivalent of 0.15% or less of hydrocyanic acid

Hydroquinone in preparations for human therapeutic or cosmetic use containing 2% or less of hydroquinone, except—

(a)monobenzone and other alkyl ethers of hydroquinone included in Schedule 4; or

(b)in hair treatment preparations containing 1% or less of hydroquinone

8-Hydroxyquinoline and its non-halogenated derivatives for human therapeutic use, except in preparations for external use containing 1% or less of such substances

Hyoscine—

(a)in preparations containing 0.25% or less of hyoscine; or

(b)in transdermal applicators containing 2 mg or less of hyoscine;

except hyoscine butylbromide included in Schedule 4

Hyoscyamine in preparations containing 0.25% or less of hyoscyamine

Hyoscyamus in preparations containing 0.25% or less of the alkaloids of hyoscyamus calculated as hyoscyamine

Iodine (excluding its salts, derivatives and iodophors) in preparations for human therapeutic use containing more than 2.5% of available iodine

Iron Compounds for human internal use, except—

(a)when included in Schedule 4;

(b)in divided preparations containing 5 mg or less of iron per dosage unit; or

(c)in liquid oral preparations containing 0.1% or less of iron

Isopropamide in preparations containing 2% or less of isopropamide for dermal use

Isosorbide Dinitrate for therapeutic use

Lignocaine when included in—

(a)lozenges, pastilles, tablets or capsules containing 30 mg or less of lignocaine in each;

(b)suppositories or bougies containing 200 mg or less of lignocaine in each; or

(c)preparations for external use, other than eye drops, containing 10% or less of lignocaine

Lindane in preparations for external human therapeutic use containing 2% or less of lindane

Lobelia—

(a)in divided preparations containing 2.5 mg or less of lobeline per dosage unit; or

(b)in undivided preparations containing 0.05% or less of lobeline;

except in preparations for smoking or burning

Lobeline—

(a)in divided preparations containing 2.5 mg or less of lobeline per dosage unit; or

(b)in undivided preparations containing 0.05% or less of lobeline;

except in preparations for smoking or burning

Luteinising Hormone Antibodies in human ovulation test kits

Maldison in preparations for external human therapeutic use containing 2% or less of maldison

Mebendazole for human therapeutic use

Mercuric Chloride in preparations containing 0.5% or less of mercuric chloride, except when included in Schedule 7

Mercuric Iodide in preparations for therapeutic use containing 2% or less of mercuric iodide

Mercuric Nitrate in preparations for therapeutic use containing 5% or less of mercuric nitrate

Mercuric Oxide and all oxides of mercury

Mercuric Potassium Iodide in preparations for therapeutic use containing the equivalent of 2% or less of mercuric iodide

Mercury Organic Compounds for topical therapeutic use in preparations containing 0.5% or less of mercury

Methoxamine, except in preparations for external use containing 1% or less of methoxamine

Methoxyphenamine

Methylephedrine

Naphazoline

Niclosamide for human therapeutic use

Nitric Esters of polyhydric alcohols for therapeutic use, except when separately specified in these Schedules

Noscapine

Oxethazaine in preparations for internal use

Oxolamine

Oxymetazoline

Papaverine

Paracetamol, except—

(a)when included in Schedule 4;

(b)tablets or capsules each containing 500 mg or less of paracetamol as the only therapeutically active constituent when—

(i)the pack is labelled—

“WARNING—THIS MEDICATION MAY BE DANGEROUS WHEN USED IN LARGE AMOUNTS OR FOR LONG PERIODS”; or

“CAUTION—THIS PREPARATION IS FOR THE RELIEF OF MINOR AND TEMPORARY AILMENTS AND SHOULD BE USED STRICTLY AS DIRECTED. PROLONGED USE WITHOUT MEDICAL SUPERVISION COULD BE HARMFUL”;

(ii)packed in blister or strip packaging or in containers with a child-resistant closure; and

(iii)in a primary pack containing not more than 25 such tablets or capsules; or

(c)in individually wrapped powders or sachets of granules each containing 1000 mg or less of paracetamol as the only therapeutically active constituent when—

(i)the pack is labelled—

“WARNING—THIS MEDICATION MAY BE DANGEROUS WHEN USED IN LARGE AMOUNTS OR FOR LONG PERIODS”; or

“CAUTION—THIS PREPARATION IS FOR THE RELIEF OF MINOR AND TEMPORARY AILMENTS AND SHOULD BE USED STRICTLY AS DIRECTED. PROLONGED USE WITHOUT MEDICAL SUPERVISION COULD BE HARMFUL”; and

(ii)in a primary pack containing not more than 12 such powders or sachets of granules

Phedrazine

Phenamazoline

Phenazone for external use

Pheniramine—

(a)in primary packs of 10 doses or less, for the prevention or treatment of motion sickness; or

(b)in oral preparations when compounded with one or more of the following medicaments:

(i)an antitussive, except codeine or dihydrocodeine;

(ii)an expectorant;

(iii)a sympathomimetic amine;

except in preparations for the treatment of children under 2 years of age

Phenol and any homologue of phenol boiling below 220 Degrees C for human therapeutic use, except in preparations containing 3% or less by weight of such substances

Phenylenediamines and alkylated phenylenediamines for therapeutic use

Phenylephrine, except—

(a)when included in Schedule 4;

(b)preparations containing 0.5% or less of phenylephrine; or

(c)preparations for external use containing 1% or less of phenylephrine

Pholcodine when compounded with one or more other therapeutically active substances—

(a)in divided preparations containing 10 mg or less of pholcodine per dosage unit and with a recommended dose not exceeding 25 mg of pholcodine; or

(b)in undivided preparations containing 0.5% or less of pholcodine and with a recommended dose not exceeding 25 mg of pholcodine

Podophyllotoxin for external human therapeutic use in preparations containing 2% or less of podophyllotoxin

Podophyllum Resin (Podophyllin) for external human therapeutic use in preparations containing 10% or less of podophyllin

Potassium Chlorate for therapeutic use, except in preparations containing 10% or less of potassium chlorate

Pramoxine when included in preparations for external use, other than eye drops, containing 1% or less of pramoxine

Procyclidine in preparations containing 5% or less of procyclidine for dermal use

Promethazine—

(a)in primary packs of 10 doses or less, for the prevention or treatment of motion sickness; or

(b)in oral preparations when compounded with one or more of the following medicaments:

(i)an antitussive, except codeine or dihydrocodeine;

(ii)an expectorant;

(iii)a sympathomimetic amine;

except in preparations for the treatment of children under 2 years of age

Propantheline in preparations for topical use

Pseudoephedrine—

(a)in divided preparations containing 60 mg or less of pseudoephedrine per recommended dose;

(b)in other divided preparations containing 120 mg or less of pseudoephedrine per recommended dose in slow release form, for which approval for the slow release characteristic has been granted by the Commonwealth Department of Community Services and Health; or

(c)in liquid preparations containing 60 mg or less of pseudoephedrine per recommended dose;

except when included in Schedule 4

Pyrantel for human therapeutic use

Pyrithione Zinc for human therapeutic use when—

(a)in semisolid hair preparations; or

(b)in shampoos labelled—

“KEEP OUT OF EYES”; or

“IF IN EYES, RINSE WELL WITH WATER”;

except in preparations containing 2% or less of pyrithione zinc

Salicylamide, except when included in Schedule 4

Silver Salts for therapeutic use, except—

(a)chewing tablets containing 5 mg or less           of silver per tablet when the pack is labelled—

“WARNING—OVERUSE MAY STAIN THE SKIN OR MOUTH”; or

(b)solutions containing 0.3% or less of silver when the pack is labelled—

“WARNING—OVERUSE MAY STAIN THE SKIN OR MOUTH”

Sodium Nitrite for therapeutic use

Sputolysin-see trans-4-((3,5-Dibromo-2-hydroxybenzyl)-amino) cyclohexanol hydrochloride monohydrate

Staphisagria, except in preparations containing 0.2% or less of staphisagria

Stramonium in preparations containing 0.25% or less of the alkaloids calculated as hyoscyamine, except preparations for smoking or burning

Tetrahydrozoline

Thenyldiamine—

(a)in nasal preparations for topical use; or

(b)in oral preparations when compounded with one or more of the following medicaments:

(i)an antitussive, except codeine or dihydrocodeine;

(ii)an expectorant;

(iii)a sympathomimetic amine;

except in preparations for the treatment of children under 2 years of age

Tramazoline

Trimeprazine in oral preparations when compounded with one or more of the following medicaments:

(a)an antitussive, except codeine or dihydrocodeine;

(b)an expectorant;

(c)a sympathomimetic amine;

except in preparations for the treatment of children under 2 years of age

Triprolidine in oral preparations when compounded with one or more of the following medicaments:

(a)an antitussive, except codeine or dihydrocodeine;

(b)an expectorant;

(c)a sympathomimetic amine;

except in preparations for the treatment of children under 2 years of age

Tymazoline

Xylometazoline

SCHEDULE 3  Section 3

Acepifylline in liquid oral preparations

Adrenaline in preparations containing 1% or less of adrenaline, except in preparations containing 0.02% or less of adrenaline

Aminophylline in liquid oral preparations

Amyl Nitrite

Azatadine in oral preparations

Benzoyl Peroxide in preparations containing 10% or less of benzoyl peroxide for external human therapeutic use, except when included in Schedule 2

Brompheniramine in oral preparations, except when included in Schedule 2

Buclizine in oral preparations, except when included in Schedule 2

Butyl Nitrite

Chloral Hydrate for human internal therapeutic use in preparations containing 5% or less of chloral hydrate, when packed in containers of 100 ml, or less

Chlorofluorocarbons—see Fluorocarbons

Chlorpheniramine in oral preparations, except when included in Schedule 2

Clemastine in oral preparations

Clotrimazole for human use in preparations containing 1% or less of clotrimazole, for treatment of fungal infections of the skin

Codeine in capsules or tablets each containing 10 mg or less of codeine when compounded with aspirin, paracetamol or salicylamide or any one of their derivatives and no other analgesic substance, except when included in Schedule 2

Cyproheptadine in oral preparations

Dexchlorpheniramine in oral preparations, except when included in Schedule 2

Dihydrocodeine when compounded with one or more other therapeutically active substances—

(a)in divided preparations containing 10 mg or less per dosage unit and with a recommended dose not exceeding 15 mg of dihydrocodeine; or

(b)in undivided preparations containing 0.25% or less of dihydrocodeine with a recommended dose not exceeding 15 mg of dihydrocodeine;

except when included in Schedule 2

Dimenhydrinate in oral preparations, except when included in Schedule 2

Dimethindene in oral preparations

Diphenhydramine in oral preparations, except when included in Schedule 2

Diphenylpyraline in oral preparations, except when included in Schedule 2

Dithranol for human therapeutic use

Doxylamine in oral preparations, except when included in Schedule 2

Econazole for human use in preparations containing 1% or less of econazole for treatment of fungal infections of the skin

Ephedrine for internal use, when compounded with one or more other therapeutically active substances, other than preparations for stimulant, appetite suppression or weight control purposes, except—

(a)when included in Schedule 2; or

(b)in liquid preparations containing 10 mg or less of ephedrine per recommended dose

Fenoterol in metered aerosols delivering 200 micrograms or less of fenoterol per metered dose

Flavoxate

Fluorides in dentifrices containing more than 1000 mg/kg of fluoride ion

Fluorocarbons and Chlorofluorocarbons alone or in combination with other propellants or refrigerants in liquified gas form for therapeutic use

Folic Acid for human therapeutic use, except in preparations containing 500 micrograms or less of folic acid per recommended daily dose

Folinic Acid for human therapeutic use, except in preparations containing 500 micrograms or less of folinic acid per recommended daily dose

Hydrocortisone and Hydrocortisone Acetate as the only therapeutically active substances in preparations for dermal use containing 0.5% or less of hydrocortisone in packs containing 30 grams or less where the labelling warns against contact with the eyes and against use for acne and on children below 2 years of age, use beyond 7 days, and use under occlusive dressings, except on medical advice

Idoxuridine in preparations containing 0.5% or less of idoxuridine for cutaneous use

Insulin

Isoconazole for human use in preparations containing 1% or less of isoconazole, for treatment of fungal infections of the skin

Loperamide in packs of 8 dosage units or less, each dosage unit containing 2 mg or less of loperamide

Mefenamic Acid in packs of 30 or less capsules for treatment of spasmodic dysmenorrhoea

Mepyramine in oral preparations

Methdilazine in oral preparations

Miconazole for human use in preparations containing 2% or less of miconazole for treatment of fungal infections of the skin

Naproxen in packs of 12 or less tablets or capsules for treatment of spasmodic dysmenorrhoea

Nicotine in chewing tablets containing 2 mg or less of nicotine per tablet for use as an aid in withdrawal from tobacco smoking

Nitrofurazone in preparations for dermal use containing 0.2% or less of nitrofurazone

Octyl Nitrite

Pheniramine in oral preparations, except when included in Schedule 2

Phenylpropanolamine in preparations for relief of coughs or colds containing 25 mg or less per dose of phenylpropanolamine

Phenyltoloxamine in oral preparations

Podophyllotoxin for external human therapeutic use in preparations containing 4% or less of podophyllotoxin, except when included in Schedule 2

Podophyllum Resin (Podophyllin) for external human therapeutic use in preparations containing 20% or less of podophyllin, except when included in Schedule 2

Promethazine in oral preparations, except when included in Schedule 2

Pseudoephedrine, except when included in Schedule 2 or 4

Quinine for human internal therapeutic use, except in liquids containing 40 mg/L or less of quinine

Salbutamol—

(a)in metered aerosols delivering 100 micrograms or less of salbutamol per metered dose; or

(b)in capsules of dry powder for inhalation delivering 200 micrograms or less of salbutamol per dose

Santonin

Sodium Cromoglycate in nasal preparations for topical use

Terbutaline in metered aerosols delivering 250 micrograms or less of terbutaline per metered dose

Thenyldiamine in oral preparations, except when included in Schedule 2

Theophylline in liquid oral preparations

Tioconazole for human use in preparations containing 1% or less of tioconazole for treatment of fungal infections of the skin

Tretinoin for external human therapeutic use

Trimeprazine—

(a)in solid oral preparations; or

(b)in liquid oral preparations containing 10 mg or less or trimeprazine per 5 ml;

except when included in Schedule 2

Triprolidine in oral preparations, except when included in Schedule 2

SCHEDULE 4  Section 3

Acebutolol

Acepifylline, except when included in Schedule 3

Acepromazine

Acetanilide and alkyl acetanilides, for human therapeutic use

Acetazolamide

Acetohexamide

Acetylcholine

Acetylcysteine

Acetyldihydrocodeine when compounded with one or more other medicaments—

(a)in divided preparations containing not more than 100 mg of acetyldihydrocodeine per dosage unit; or

(b)in undivided preparations with a concentration of not more than 2.5% of acetyldihydrocodeine

Acetylmethyldimethyloximidophenylhydrazine

Actinomycin D (Dactinomycin)

Acyclovir

Adiphenine

Adrenaline, except—

(a)when included in Schedule 3; or

(b)in preparations containing 0.02% or less of adrenaline

Alcuronium salts

Allopurinol

Alphadolone

Alphaxalone

Alprazolam

Alprenolol

Alprostadil

Amantadine

Ambenonium

Ambucetamide

Ambutonium

Amethocaine

Amikacin

Amiloride

Aminocaproic Acid

Amioglutethimide

Aminometradine

Aminophenazone and derivatives therefrom for the treatment of animals

Aminophylline, except when included in Schedule 3

Aminopterin

4-Aminopyridine

Aminorex

Aminosalicylic Acid

Amiodarone

Amiphenazole

Amisometradine

Amitriptyline

Amodiaquine

Amoxycillin

Amphomycin

Amphotericin

Ampicillin

Amsacrine

Amylobarbitone when packed and labelled for injection

Amylocaine

Anabolic Steroidal Agents, except when separately specified in these Schedules

Angiotensin Amide

Antazoline, except when included in Schedule 2

Antibiotics, except—

(a)when separately specified in these Schedules; or

(b)nisin

Antihistamines, except—

(a)when included in Schedule 2 or 3; or

(b)when separately specified in this Schedule

Antimony, organic compounds of, for therapeutic use

Apomorphine

Aprotinin

Arsenic—see Thiacetarsamide

Aspirin when combined with caffeine, paracetamol or salicylamide or any derivative of these substances

Atenolol

Atracurium Besylate

Atropine Methonitrate

Auranofin

Avoparcin, except when packed and labelled for use as an animal feed additive

Azaperone

Azapetine

Azatadine, except when included in Schedule 3

Azlocillin

Aztreonam

Bacampicillin

Bacitracin, except—

(a)when included in Schedule 6;

(b)in animal feeds for growth promotion containing 50 mg/kg or less of antibiotic substances; or

(c)in milk replacers for calves and starter rations for pigs containing 100 mg/kg or less of antibiotic substances

Baclofen

Bamipine

Barbituric Acid and its derivatives, except—

(a)when included or separately specified in Schedule 8; or

(b)when separately specified in this Schedule

Beclamide

Bemegride

Benactyzine, and other substances structurally derived from diphenylmethane with ataractic properties, when used for therapeutic purposes

Bendrofluazide

Benorylate

Benserazide

Benzamine, except when included in Schedule 2

Benzhexol

Benzilonium

Benzocaine, except when included in Schedule 2

Benzodiazepine derivatives, except when separately specified in these Schedules

Benzoyl Peroxide in preparations for external human therapeutic use, except when included in Schedule 2 or 3

Benzphetamine and other substances structurally derived from β‑aminopropylbenzene or β-aminoisopropylbenzene by substitution in the side chain or by ring closure therein (or by both such substitution and such closure), except—

(a)where separately specified in this or any other Schedule; or

(b)ephedrine in preparations exempted from Schedule 2

Benztropine

Benzydamine, except when included in Schedule 2

Benzylpenicillin (including procaine penicillin), except when included in Schedule 6

Betahistine

Bethanechol Chloride

Bethanidine

Bifonazole

Biperiden

Bismuth compounds for human therapeutic or cosmetic use, except—

(a)bismuth citrate when incorporated in hair colourant preparations in concentrations of 0.5% or less;

(b)bismuth oxychloride in cosmetics; or

(c)bismuth formic iodide or bismuth subiodide in dusting powders containing 3% or less of bismuth

Bleomycin

Boron for human therapeutic use—

(a)for internal use;

(b)in glycerines or honeys of borax or boric acid;

(c)in dusting powders for paediatric use; or

(d)as a therapeutically active ingredient in other preparations for dermal use except—

(i)in antifungal preparations; or

(ii)in preparations containing 0.1% or less of boron

Bretylium

Bromazepam

Bromides, inorganic, for therapeutic use

Bromocriptine

Bromoform for therapeutic use

Brompheniramine, except when included in Schedule 2 or 3

Bromvaletone

Buclizine, except when included in Schedule 2 or 3

Bufexamac, except in preparations containing 5% or less of bufexamac for external human therapeutic use, including suppositories

Bumetanide

Bupivacaine

Buprenorphine

Buspirone

Busulphan

Butacaine

Butylaminobenzoate, except when included in Schedule 2

Butylchloral Hydrate

Calcitonin

Calcitriol

Calcium Carbimide for therapeutic use

Camphorated Oil excluding admixtures

Camphotamide

Candicidin

Canine Tick Anti-serum

Cantharidin

Capreomycin

Captodiame

Captopril

Capuride

Caramiphen

Carbachol

Carbamazepine

Carbaryl for human therapeutic use, except when included in Schedule 2

Carbazochrome

Carbenicillin

Carbenoxolone, except when included in Schedule 2

Carbidopa

Carbimazole

Carbocromen

Carboplatin

Carbromal

Cardiac Glycosides, except when separately specified in these Schedules

Carindacillin

Carmustine

Carnidazole for the treatment of pigeons

Cathine

Cefaclor

Cefoperazone

Cefotaxime

Cefotetan

Cefoxitin

Ceftazidime

Ceftriaxone

Cephacetrile

Cephadroxil for the treatment of animals

Cephalexin

Cephaloridine

Cephalothin

Cephamandole

Cephapirin

Cephazolin

Cephradine

Chenodeoxycholic Acid

Chloral Formamide

Chloral Hydrate, except—

(a)when included in Schedule 3; or

(b)in preparations for topical use containing 2% or less of chloral hydrate

α-Chloralose—see Chloralose

Chloralose, except when included in Schedule 6

Chlorambucil

Chloramphenicol

Chlorazanil

Chlorbutol in preparations for human oral use, except in preparations containing 0.5% or less of chlorbutol as a preservative

Chlorcyclizine

Chlordiazepoxide

Chlormerodrin

Chlormethiazole

Chlormezanone

Chloroform for use in anaesthesia

2-(4-Chlorophenyl)-1, 2, 4-triazole [5, 1a]-isoquinoline for the treatment of animals

Chloroquine

Chlorothiazide

Chlorpheniramine, except when included in Schedule 2 or 3

Chlorphentermine

Chlorpromazine

Chlorpropamide

Chlorprothixene

Chlortetracycline, except when included in Schedule 6

Chlorthalidone

Chlorzoxazone

Cholestyramine for human therapeutic use

Chymopapain, injection for human therapeutic use

Ciclacillin

Cilastatin

Cimetidine

Cinchocaine

Cinoxacin

Ciprofloxacin

Cisplatin

Clanobutin in injections for the treatment of animals

Clavulanic Acid

Clemastine, except when included in Schedule 3

Clemizole

Clenbuterol for the treatment of animals

Clidinium

Clindamycin

Clobazam

Clobetasone-17-butyrate

Clofenamide

Clofibrate

Clomiphene

Clomipramine

Clomocycline

Clonazepam

Clonidine

Clopamide

Cloprostenol for the treatment of animals

Clorazepate

Clorexolone

Clorprenaline

Clotrimazole, except when included in Schedule 3 or 6

Cloxacillin

Clozapine

Codeine when compounded with one or more other therapeutically active substances—

(a)in divided preparations containing 30 mg or less of codeine per dosage unit; or

(b)in undivided preparations containing 1% or less of codeine;

except when included in Schedule 2 or 3

Colaspase

Colchicine

Colestipol for human therapeutic use

Colistin

Cortisone and steroid suprarenal cortical hormones, except hydrocortisone in Schedule 3

Curare

Cyclandelate

Cyclizine

Cyclofenil

Cyclopenthiazide

Cyclopentolate

Cyclophosphamide

Cyclopropane for therapeutic use

Cycloserine

Cyclosporin

Cyclothiazide

Cycrimine

Cyproheptadine, except when included in Schedule 3

Cyproterone

Cytarabine

Dacarbazine

Danazol

Dantrolene

Dapsone

Daunorubicin

Deanol

Debrisoquine

Demecarium Bromide

Demeclocycline

Desipramine

Desmopressin (DDAVP)

Detomidine for the treatment of animals

Dexchlorpheniramine, except when included in Schedule 2 or 3

Dextromethorphan, except when included in Schedule 2

Dextropropoxyphene—

(a)in divided preparations containing 135 mg or less of dextropropoxyphene per dosage unit; or

(b)in liquid preparations containing 2.5% or less of dextropropoxyphene

Dextrorphan

Diazepam

Diazoxide

Dibenzepin

trans-4-((3,5-Dibromo-2-hydroxybenzyl)-amino) cyclohexanol hydrochloride monohydrate (Sputolysin), except when included in Schedule 2

Dichloralphenazone

Dichlorphenamide

Diclofenac

Dicyclomine, except when included in Schedule 2

Diethazine

Diethylcarbamazine for human therapeutic use

Diethylpropion

Difenoxin in preparations containing, per dosage unit, 0.5 mg or less of difenoxin and a quantity of atropine sulphate equivalent to at least 5% of the dose of difenoxin

Diflunisal

Digitalis and its glycosides

Digoxin Antibody

Dihydralazine

Dihydrocodeine when compounded with one or more other medicaments—

(a)in divided preparations containing not more than 100 mg of dihydrocodeine per dosage unit; or

(b)in undivided preparations with a concentration of not more than 2.5% of dihydrocodeine;

except when included in Schedule 2 or 3

Dihydrostreptomycin, except when included in Schedule 6

Diisopropylamine Dichloroacetate

Diltiazem

Dimenhydrinate, except when included in Schedule 2 or 3

Dimethindene, except when included in Schedule 3

Dimethisoquin, except when included in Schedule 2

Dimethoxanate

Dimethyl Sulphoxide for therapeutic use, except—

(a)when included in Schedule 6; or

(b)in invitro test kits

Dimetridazole

Dinitrocresols for therapeutic use

Dinitronaphthols for therapeutic use

Dinitrophenols for therapeutic use

Dinitrothymols for therapeutic use

Dinoprost

Diperodon

Diphemanil Methylsulphate, except when included in Schedule 2

Diphenhydramine, except when included in Schedule 2 or 3

Diphenidol

Diphenoxylate in preparations containing, per dosage unit, 2.5 mg or less of diphenoxylate and a quantity of atropine sulphate equivalent to at least 1% of the dose of diphenoxylate

Diphenylpyraline, except when included in Schedule 2 or 3

Dipivefrin

Dipyridamole

Disophenol

Disopyramide

Distigmine

Disulfiram for therapeutic use

Dithiazanine, except when included in Schedule 6

Dobutamine

Domperidone

Dopamine

Dothiepin

Doxapram

Doxepin

Doxorubicin

Doxycycline

Doxylamine, except when included in Schedule 2 or 3

Droperidol

Drostanolone

Econazole, except when included in Schedule 3 or 6

Edetic Acid for human therapeutic use in preparations for injection or infusion

Emetine, except in preparations containing 0.2% or less of emetine

Enalapril

Enflurane for therapeutic use

Ephedrine except—

(a)when included in Schedule 2 or 3;

(b)in preparations for topical use containing 1% or less of ephedrine; or

(c)when compounded with one or more other therapeutically active substances in liquid preparations for internal use containing 10 mg or less of ephedrine per recommended dose, other than preparations for stimulant, appetite suppression or weight control purposes

Epicillin

Epirubicin

Ergometrine

Ergot

Ergotamine

Erythromycin, except—

(a)when included in Schedule 6;

(b)in animal feeds for growth promotion containing 50 mg/kg or less of antibiotic substances; or

(c)in milk replacers for calves and starter rations for pigs containing 100 mg/kg or less of antibiotic substances

Estramustine

Ethacrynic Acid

Ethambutol

Ethamivan

Ethchlorvynol

Ether for use in anaesthesia

Ethinamate

Ethoglucid

Ethoheptazine, except when included in Schedule 2

Ethopropazine

Ethosuximide

Ethotoin

Ethoxzolamide

N-Ethylamphetamine

Ethyl Chloride for inhalation anaesthesia

Ethylmorphine when compounded with one or more other medicaments—

(a)in divided preparations containing not more than 100 mg of ethylmorphine per dosage unit; or

(b)in undivided preparations with a concentration of not more than 2.5% of ethylmorphine;

except when included in Schedule 2

Ethyloestrenol

Etidocaine

Etidronate, except in tooth pastes and gels containing 1% or less of

etidronate

Etilefrin Hydrochloride

Etoposide

Etretinate

Felypressin

Fencamfamin

Fenfluramine

Fenoprofen

Fenoterol, except when included in Schedule 3

Fenpipramide

Fenpiprane

Fenproporex

Fenprostalene for the treatment of animals

Flavophospholipol, except—

(a)when included in Schedule 6; or

(b)in animal feeds for growth promotion containing 50 mg/kg or less of antibiotic substances

Flecainide

Flucloxacillin

Flucytosine

Flufenamic Acid

Flunisolide

Flunitrazepam

Flunixin Meglumine for the treatment of animals

Fluorides in preparations for human ingestion, except when included in Schedule 2 or 3

Fluorouracil

Fluoxymesterone

Fluphenazine

Fluprostenol for the treatment of animals

Flurazepam

Fluroxene for inhalation anaesthesia

Fluspirilene

Follicle Stimulating Hormone-see Gonadotrophins

Framycetin

Frusemide

Fusidic Acid

Galanthamine

Gallamine

Gemeprost

Gentamicin

Glibenclamide

Glibornuride

Gliclazide

Glipizide

Glucagon

Glutethimide

Glyceryl Trinitrate in preparations for injection

Glycopyrrolate

Glymidine

Gonadorelin

Gonadotrophins, except when included in Schedule 2

Gramicidin

Griseofulvin

Growth Hormone

Guaiphenesin, except when included in Schedule 2

Guanabenz

Guanacline

Guanethidine

Halcinonide

Haloperidol and other substances structurally derived from butyrophenone with ataractic properties, when used for therapeutic purposes, except when separately specified in this Schedule

Halothane for therapeutic use

Heparin for internal therapeutic use

Hetacillin

Hexachlorophane—

(a)in preparations for use on infants; or

(b)in other preparations, except when included in Schedule 2 or 6

Hexamethonium

Hexocyclium

Hyaluronic Acid in preparations for injection

Hydralazine

Hydrochlorothiazide

Hydroflumethiazide

Hydroquinone in preparations for human therapeutic or cosmetic use, except—

(a)when included in Schedule 2;

(b)alkyl ethers of hydroquinone separately specified in this Schedule; or

(c)in hair treatment preparations containing 1% or less of hydroquinone

Hydroxychloroquine

1-Hydroxypyrido (3,2,a)-5-phenoxazone-3-carboxylic Acid

Hydroxyurea

Hydroxyzine

Hygromycin, except—

(a)when included in Schedule 6; or

(b)in preparations in concentrations of 50 mg/kg or less of antibiotic substances

Hyoscine Butylbromide

Hypothalamic Releasing Factors, except when separately specified in this Schedule

Ibufenac

Ibuprofen

Idoxuridine, except when included in Schedule 3

Imipenem

Imipramine

Indapamide

Indomethacin

Inositol Nicotinate for internal use

Interferon

Ion-exchange Resins, anionic and cationic, for internal use in humans, except when separately specified in this Schedule

Iopamidol

Ipratropium

Iproniazid

Iron compounds in injectable preparations for human therapeutic use

Isoaminile

Isocarboxazid

Isoconazole, except when included in Schedule 3 or 6

Isoetharine

Isoflurane for therapeutic use

Isometheptene

Isoniazid

Isoprenaline

Isopropamide, except when included in Schedule 2

Isotretinoin

Isoxuprine

Kanamycin

Ketamine

Ketoconazole

Ketoprofen

Khellin

Kitasamycin, except—

(a)when included in Schedule 6; or

(b)in animal feeds for growth promotion containing 100 mg/kg or less of antibiotic substances

Labetalol

Latamoxef

Laudexium Methylsulphate

Lead Compounds for human therapeutic use

Lefetamine

Leptazol

Leuprorelin

Levallorphan

Levamisole—

(a)for human therapeutic use; or

(b)in preparations for the prevention or treatment of heartworm in dogs

Levodopa

Lidoflazine

Lignocaine, except when included in Schedule 2

Lincomycin

Lindane for human therapeutic use, except when included in Schedule 2

Liothyronine Sodium (Triiodothyronine)

Lithium salts for therapeutic use, except in preparations containing 0.01% or less of lithium

Lomustine

Loperamide, except when included in Schedule 3

Lorazepam

Loxapine

Luteinising Hormone--see Gonadotrophins

Lymecycline

Mafenide, except when included in Schedule 6

Maldison for human therapeutic use, except when included in Schedule 2

Maprotiline

Mazindol

Mebeverine

Mebhydrolin

Mecamylamine

Meclofenoxate

Meclozine

Medazepam

Mefenamic Acid, except when included in Schedule 3

Mefenorex

Mefloquine

Mefruside

Melphalan

Mepacrine

Mepenzolate

Mephenesin and its derivatives, except guaiphenesin where specified in Schedule 2 or 4

Mephentermine

Mepivacaine

Meprobamate

Mepyramine, except when included in Schedule 3

Mercaptopurine

Mercurous Chloride for internal therapeutic use

Mercury (metallic) for therapeutic use

Mercury Organic Compounds for therapeutic use, except when included in Schedule 2

Metaraminol

Metergoline for the treatment of animals

Metformin

Methacycline

Methandienone

Methandriol

Methanthelinium

Methazolamide

Methdilazine, except when included in Schedule 3

Methenolone

Methicillin

Methimazole

Methixene

Methocarbamol

Methoin

Methotrexate

Methoxsalen

Methoxyflurane for therapeutic use

Methsuximide

Methyclothiazide

Methylandrostanolone

Methyldopa

Methylpentynol and other substituted alkynes for internal use

Methyprylone

Methysergide

Metoclopramide

Metolazone

Metoprolol

Metrizamide

Metronidazole including benzoyl metronidazole

Metyrapone

Mexiletine

Mezlocillin

Mianserin

Mibolerone

Miconazole, except when included in Schedule 3 or 6

Midazolam

Minocycline

Minoxidil

Misoprostol

Mithramycin

Mitobronitol

Mitomycin

Mitozantrone

Monensin, except—

(a)when included in Schedule 6; or

(b)in animal feeds containing 33 mg/kg or less of antibiotic substances

Monobenzone and other alkyl ethers of hydroquinone for human therapeutic or cosmetic use

Monoclonal Antibodies for therapeutic use, except in diagnostic test kits

Moperone

Mupirocin

Mustine

Nadolol

Nalbuphine

Nalidixic Acid, except when included in Schedule 6

Nalorphine

Naloxone

Nandrolone

Naproxen, except when included in Schedule 3

Narasin, except—

(a)when included in Schedule 6; or

(b)in animal feeds containing 100 mg/kg or less of antibiotic substances

Natamycin

Neomycin, except when included in Schedule 6

Neostigmine

Netilmicin

Nicocodine when compounded with one or more other medicaments—

(a)in divided preparations containing not more than 100 mg of nicocodine per dosage unit; or

(b)in undivided preparations with a concentration of not more than 2.5% of nicocodine

Nicodicodine when compounded with one or more other medicaments—

(a)in divided preparations containing not more than 100 mg of nicodicodine per dosage unit; or

(b)in undivided preparations with a concentration of not more than 2.5% of nicodicodine

Nicotine in chewing tablets containing 4 mg or less of nicotine per tablet for use as an aid in withdrawal from tobacco smoking, except when included in Schedule 3

Nicotinic Acid for human therapeutic use, except—

(a)in preparations containing 50 mg or less of nicotinic acid per recommended daily dose; or

(b)nicotinamide

Nicotinyl Alcohol for internal use

Nicoumalone for internal therapeutic use

Nifedipine

Nifenazone

Nikethamide

Niridazole

Nitrazepam

Nitrofuran and its derivatives for human therapeutic use, except when included in Schedule 3

Nitrous Oxide for therapeutic use

Nomifensine

Noradrenaline, excluding its derivatives

Norcodeine when compounded with one or more other medicaments—

(a)in divided preparations containing not more than 100 mg of norcodeine per dosage unit; or

(b)in undivided preparations with a concentration of not more than 2.5% of norcodeine

Norethandrolone

Norfloxacin

Nortriptyline

Novobiocin, except when included in Schedule 6

Nystatin

Octamylamine

Octatropine

Oleandomycin, except—

(a)when included in Schedule 6; or

(b)in animal feeds for growth promotion containing 50 mg/kg or less of antibiotic substances

Opipramol

Orciprenaline

Organophosphorus Compounds with anticholinesterase activity for human therapeutic use, except—

(a)when included in Schedule 2; or

(b)when separately specified in this Schedule

Ornidazole

Ornipressin

Orphenadrine

Orthocaine

Orthopterin

Oxacillin

Oxandrolone

Oxazepam

Oxpentifylline

Oxprenolol

Oxybuprocaine

Oxymesterone

Oxymetholone

Oxyphenbutazone

Oxyphencyclimine

Oxyphenonium

Oxytetracycline, except when included in Schedule 6

Oxytocin

Pamaquine

Pancuronium Bromide

Paracetamol when combined with aspirin, caffeine or salicylamide or any derivative of these substances

Paraldehyde

Paromomycin

Pemoline

Pempidine

Penicillamine

Pentamethonium

Penthienate

Pentobarbitone when packed and labelled for injection

Pentolinium

Perhexilene

Pericyazine

Perphenazine

Phenacemide

Phenacetin for therapeutic use

Phenazone, except when included in Schedule 2

Phenazopyridine

Phenelzine

Phenethicillin, except when included in Schedule 6

Phenformin

Phenglutarimide

Phenindione for internal therapeutic use

Pheniramine, except when included in Schedule 2 or 3

Phenoxybenzamine

Phenoxymethylpenicillin, except when included in Schedule 6

Phensuximide

Phentermine

Phenthimentonium

Phentolamine

Phenyapin

Phenylbutazone

Phenylephrine in preparations for human ophthalmic use containing 5% or more of phenylephrine

Phenylpropanolamine, except when included in Schedule 3

Phenyltoloxamine, except when included in Schedule 3

Phenytoin

Pholcodine when compounded with one or more other medicaments—

(a)in divided preparations containing not more than 100 mg of pholcodine per dosage unit; or

(b)in undivided preparations with a concentration of not more than 2.5% of pholcodine;

except when included in Schedule 2

Physostigmine

Picrotoxin

Pilocarpine, except in preparations containing 0.025% or less of pilocarpine

Pimozide

Pindolol

Pipenzolate

Piperacillin

Piperidolate

Pipobroman

Pipradrol

Pirenzepine

Piroxicam

Pituitary and its extracts and active principles or their synthetic substitutes, except when separately specified in this Schedule

Pizotifen

Podophyllotoxin for human therapeutic use, except when included in Schedule 2 or 3

Podophyllum Resin (Podophyllin) for human therapeutic use, except when included in Schedule 2 or 3

Polymethylene Bistrimethyl Ammonium Compounds

Polymyxin

Polysulphated Glycosaminoglycans in preparations for injection, except where otherwise specified in this Schedule

Potassium Perchlorate for therapeutic use

Practolol

Pramoxine, except when included in Schedule 2

Prazepam

Prazosin

Pregnenolone Acetate, except in preparations for topical use

Prenylamine

Prilocaine

Primaquine

Primidone

Probenecid

Probucol

Procainamide

Procaine

Procarbazine

Prochlorperazine

Procyclidine, except when included in Schedule 2

Proguanil

Prolintane

Promazine

Promethazine, except when included in Schedule 2 or 3

Propanidid

Propantheline, except when included in Schedule 2

Propofol

Propoxur for human therapeutic use

Propranolol

Propylhexedrine

Propylthiouracil

Propyphenazone

Proquazone

Prostaglandins, except when separately specified in this Schedule

Prostianol for the treatment of animals

Prothionamide

Protirelin (thyrotrophin releasing factor)

Protriptyline

Proxymetacaine

Pseudoephedrine in preparations for stimulant, appetite suppression or weight control purposes

Pyrazinamide

Pyridostigmine

Pyridoxine Hydrochloride in preparations for human use containing more than 50 mg of pyridoxine per recommended daily dose, unless labelled—

“WARNING—THIS MEDICATION MAY BE DANGEROUS WHEN USED IN LARGE AMOUNTS OR FOR A LONG TIME”; or

“WARNING—THIS PRODUCT CONTAINS PYRIDOXINE HYDROCHLORIDE WHICH MAY BE DANGEROUS WHEN USED IN LARGE AMOUNTS OR FOR A LONG TIME”

Pyrimethamine

Pyrovalerone

Quinethazone

Quinidine

Ranitidine

Rauwolfia Serpentina

Ribavirin

Rifampicin

Rimiterol Hydrobromide

Ritodrine

Rolitetracycline

Rosoxacin

Salbutamol, except when included in Schedule 3

Salicylamide when combined with aspirin, caffeine or paracetamol or any derivative of these substances

Salinomycin, except—

(a)when included in Schedule 6; or

(b)in animal feeds containing 60 mg/kg or less of antibiotic substances

Selenium, except—

(a)when included in Schedule 5 or 6;

(b)as selenium arsenide in photocopier drums;

(c)in animal feeds containing 0.1 g/tonne or less of selenium;

(d)in compressed pellets for control of selenium responsive conditions in sheep or cattle; or

(e)in fertilizers containing 200 g/tonne or less of selenium

Semisodium Valproate

Sex Hormones and all substances having sex hormonal activity, except when separately specified in these Schedules

Silver Sulphadiazine

Sisomycin

Sodium Cellulose Phosphate for human internal use

Sodium Cromoglycate, except when included in Schedule 3

Sodium Nitroprusside for human therapeutic use

Sodium Pentosan Polysulphate for the treatment of animals

Sodium Valproate

Sontoquine

Sotalol

Sparteine

Spectinomycin

Spiramycin, except—

(a)when included in Schedule 6; or

(b)in animal feeds for growth promotion in pigs or poultry containing 50 mg/kg or less of antibiotic substances

Spironolactone

Sputolysin—see trans-4-((3,5-Dibromo-2-hydroxybenzyl)-amino) cyclohexanol hydrochloride monohydrate

Stanolone

Stanozolol

Streptomycin, except when included in Schedule 6

Strophanthus and its glycosides

Strychnine in preparations containing 1.5% or less of strychnine for the treatment of animals

Sulfadoxine

Sulfametrole

Sulindac

Sulphanilamide and its derivatives, except—

(a)when included in Schedule 6;

(b)when separately specified in this Schedule;

(c)oryzalin;

(d)sulphaquinoxaline in animals feeds containing 200 mg/kg or less of sulphaquinoxaline; or

(e)sulphaquinoxaline when incorporated in baits for the destruction of vermin

Sulphatroxazole for the treatment of animals

Sulphinpyrazone

Sulphomyxin

Sulphonal and alkyl sulphonals

Sulthiame

Suxamethonium Salts

Tacrine

Tamoxifen

Temazepam

Teniposide

Terbutaline, except when included in Schedule 3

Terfenadine

Teropterin

Tetrabenazine

Tetracosactrin

Tetracycline, except when included in Schedule 6

Thalidomide

Thenyldiamine, except when included in Schedule 2 or 3

Theophylline, except when included in Schedule 3

Thiacetarsamide in preparations for the prevention or treatment of heart worm in dogs

Thiacetazone

Thiambutosine

Thiazosulphone

Thiethylperazine

Thioguanine

Thiopropazate

Thioridazine

Thiotepa

Thiothixene

Thiouracil

Thiourea for therapeutic use

Thyroid and its extracts and active principles, except when separately specified in this Schedule

Thyrotrophin (TSH)

Thyroxine Sodium

Tiamulin, except—

(a)when included in Schedule 6; or

(b)in prepared animal feeds

Ticarcillin

Tiemonium

Tigloidine

Tiletamine for the treatment of animals

Timolol

Tinidazole

Tioconazole, except when included in Schedule 3

Tipepidine

Tobramycin

Tocainide

Tolazamide

Tolazoline for internal use

Tolbutamide

Tolpropamine

Tranexamic Acid

Tranylcypromine

Tretamine

Triamterene

Triaziquone

Triazolam

Trichloroethylene for therapeutic use

Triclofos

Tricyclamol

Tridihexethyl

Trifluoperazine

Trifluperidol

Trimeprazine, except when included in Schedule 2 or 3

Trimetaphan

Trimethoprim

Trimipramine

Trimustine

Trioxysalen

Tripelennamine

Triprolidine, except when included in Schedule 2 or 3

Tropicamide

Troxidone

Tubocurarine

Tylosin, except—

(a)when included in Schedule 6;

(b)in animal feeds for growth promotion containing 50 mg/kg or less of antibiotic substances; or

(c)in milk replacers for calves or starter rations for pigs containing 100 mg/kg or less of antibiotic substances

Urethane, excluding its derivatives, for therapeutic use

Vaccines, sera, toxoids and antigens, for human parenteral use

Vaccines, veterinary live virus, except—

(a)poultry vaccines;

(b)pigeon pox vaccine; or

(c)scabby mouth vaccine

Valnoctamide

Vancomycin

Vasopressin

Vecuronium Bromide

Verapamil

Veratrum for therapeutic use

Vidarabine

Vinblastine

Vinca Alkaloids, except when separately specified in this Schedule

Vincristine

Vindesine

Viprynium

Virginiamycin, except—

(a)when included in Schedule 6; or

(b)in animal feeds for growth promotion containing 50 mg/kg or less of antibiotic substances

Visnadine

Vitamin A for human therapeutic use, except in preparations containing 10 000 I.U. or less of vitamin A per recommended daily dosage

Vitamin D for human therapeutic use, except in preparations containing 25 micrograms or less of vitamin D per recommended daily dosage

Warfarin for internal therapeutic use

Xanthinol Nicotinate

Xylazine

Yohimbine

Zeranol, except when included in Schedule 6

Zinc Compounds for human internal use, except—

(a)in preparations with a recommended daily dose of 50 mg or less, but more than 25 mg, of zinc when the pack is labelled—

“WARNING — THIS MEDICATION MAY BE DANGEROUS WHEN USED IN LARGE AMOUNTS OR FOR LONG PERIODS”; or

“WARNING — THIS PRODUCT CONTAINS ZINC WHICH MAY BE DANGEROUS WHEN USED IN LARGE AMOUNTS OR FOR A LONG PERIOD”; or

(b)in preparations with a recommended daily dose of 25 mg or less of zinc

Zolazepam for the treatment of animals

SCHEDULE 5  Section 3

Acetic Acid (excluding its salts and derivatives) in preparations containing more than 30% of acetic acid, except—

(a)when included in Schedule 2 or 6; or

(b)for therapeutic use

Acetic Anhydride (excluding its salts and derivatives) in preparations containing more than 30% of acetic anhydride, except—

(a)when included in Schedule 6; or

(b)for therapeutic use

Acetone, except—

(a)in preparations containing 25% or less of acetone; or

(b)in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of acetone

Acetophenone—see Phenyl Methyl Ketone

Aklomide

Alkaline Salts, being the carbonate, orthosilicate, metasilicate or tribasic phosphate salts of sodium or potassium, in any combination, except—

(a)in preparations containing 10% or less of combined substances;

(b)in solid preparations whose pH in 10 g/L aqueous solution is 11.5 or less; or

(c)in liquid preparations having a pH of 11.5 or less

Alloxydim

Alphamethrin—see Cypermethrin

Ametryn

Amines—see Epoxy Resins

Amitrole

Ammonia and Ammonium Hydroxide (excluding their salts and derivatives) in preparations containing 5% or less of free ammonia, except—

(a)in preparations for human internal therapeutic use;

(b)in preparations for inhalation when absorbed in an inert solid material; or

(c)in preparations containing 0.5% or less of free ammonia

Ammonium Thiocyanate, except in preparations containing 10% or less of ammonium thiocyanate

Anhydrides—see Epoxy Resins

Arsenic organic compounds in herbicides or defoliant preparations containing 3% or less of arsenic, except when separately specified in this Schedule

Azamethiphos

Barium Silicofluoride when coated on paper in an amount not exceeding 8 mg per sq. cm.

Bendiocarb in preparations containing 2% or less of bendiocarb

Bentazone

Benzoyl Peroxide, except—

(a)when included in Schedule 2, 3 or 4; or

(b)in preparations containing 2% or less of benzoyl peroxide

BHC (excluding the γ-isomer) in preparations containing 10% or less of BHC

Bioallethrin (including sinbioallethrin), except in preparations containing 10% or less of bioallethrin

Bioresmethrin, except in preparations containing 10% or less of bioresmethrin

Boric Acid (excluding its salts) and Borax, except—

(a)when included in Schedule 4;

(b)in preparations, other than insect baits, containing 1% or less of boron; or

(c)in hand cleaning preparations

Buthidazole

Butoxycarboxim in solid preparations containing 10% or less of butoxycarboxim

Cadmium Sulphide in preparations containing 2.5% or less of cadmium sulphide for human therapeutic use

Calcium Hypochlorite, except in preparations containing 4% or less of available chlorine

Camphor, except—

(a)when included in   Schedule 4; or

(b)in preparations containing 10% or less of camphor

Carbaryl—

(a)in preparations containing 10% or less of carbaryl, except when included in Schedule 2 or 4; or

(b)when impregnated into plastic resin material containing 20% or less of carbaryl

Chlorfenac

Chlorfenson

Chlorinated Lime and preparations containing more than 4% of available chlorine

Chlorinating Compounds, except—

(a)when separately specified in these Schedules;

(b)in preparations, other than liquid preparations, containing 4% or less of available chlorine; or

(c)in liquid preparations containing-

(i)2% to 4% of available chlorine which are labelled—“WARNING—ENSURE ADEQUATE VENTILATION WHEN USING. VAPOUR MAY BE HARMFUL”; or

(ii)less than 2% of available chlorine

Chlornidine

Chlorocresol, except in preparations containing 3% or less of chlorocresol

Chlorpyrifos in preparations containing 5% or less of chlorpyrifos

Chlorsulfuron

Clanobutin for the treatment of animals, except when included in Schedule 4

Climbazole in preparations containing 40% or less of climbazole, except in preparations containing 2% or less of climbazole

Clofentezine

Clopyralid

Copper Sulphate, except—

(a)in preparations for internal use; or

(b)in other preparations containing 5% or less of copper sulphate

4-CPA

Cuprimyxin for the treatment of animals

Curing Agents—see Epoxy Resins

Cyanatryn

Cyanuric Acid, excluding its salts and derivatives

Cyclohexanone Peroxide

Cycloprothrin, except in preparations containing 10% or less of cycloprothrin

Cyfluthrin—

(a)in wettable powders containing 10% or less of cyfluthrin; or

(b)in emulsifiable concentrates containing 2% or less of cyfluthrin

Cypermethrin in preparations containing 10% or less of cypermethrin

2,4-D

2,4-DB

DDT in preparations containing 10% or less of DDT, except dicophane when included in Schedule 2

2,4-DES

N,N-Diallyldichloroacetamide, except in preparations containing 10% or less of N,N-diallyldichloroacetamide

Diazinon in dust preparations containing 2% or less of diazinon

Dichlofluanid

Dicamba

Dichlone

Dichloroisocyanurates, except in preparations containing 4% or less of available chlorine

Dichlorophen for the treatment of animals

Dichlorvos—

(a)when impregnated in plastic resin strip material containing 20% or less of dichlorvos;

(b)in sustained release resin pellets containing 20% or less of dichlorvos for the treatment of animals; or

(c)in pressurised spray packs containing 10 grams or less of dichlorvos

Diclobutrazol

Dicloran

Dicofol

Dicophane—see DDT

Diethyltoluamide, except in preparations containing 20% or less of diethyltoluamide which are labelled—

“WARNING—DO NOT DELIBERATELY SNIFF THIS PRODUCT. SNIFFING MIGHT HARM OR KILL YOU”

Dimethirimol

Dimethylformamide in preparations containing 10% or less of dimethylformamide, except in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of dimethylformamide

Diphenamid

Dodine

DSMA in herbicides or defoliant preparations containing 3% or less of arsenic

Enilconazole

Epoxy Resins in liquid form and all amines and organic anhydrides used as curing agents for epoxy resins

EPTC

Ethephon, excluding its salts and derivatives

Ether in preparations containing more than 10% of ether for use in internal combustion engines

Ethofumesate

Ethoxyquin, except in preparations containing 10% or less of ethoxyquin

Ethylene Glycol when packed and labelled as a boiling point and/or freezing point modifier and containing 10 mg/kg of denatonium benzoate as a bittering agent

Fenarimol

Fenoprop

Fenson

Fenthion in preparations containing 20% or less of fenthion when packed in single-use containers having a capacity of 1.0 ml or less

Flamprop-methyl

Fluchloralin

Flumethrin in oil based preparations containing 1% or less of flumethrin

Fluoride and Silicofluoride Ion in preparations containing 0.5% or less of fluorides and silicofluorides, except—

(a)in dentifrices containing 1000 mg/kg or less of fluoride and silicofluoride ion; or

(b)in preparations containing 15 mg/kg or less of fluoride and silicofluoride ion

Fluvalinate in aqueous preparations containing 25% or less of fluvalinate

Formic Acid (excluding its salts and derivatives), except in preparations containing 0.5% or less of formic acid

Fospirate when impregnated in plastic resin strip material containing 20% or less of fospirate

Furalaxyl

Glutaraldehyde in preparations containing 5% or less of glutaraldehyde, except when included in Schedule 2

Glyphosate

Hexazinone

Hydramethylnone in solid baits containing 2% or less of hydramethylnone in welded plastic labyrinths

Hydrocarbons in liquid form (including kerosene, mineral turpentine, white petroleum spirit, toluene, xylene and light mineral and paraffin oils (but excluding their derivatives)) distilling under 300ºC, except—

(a)toluene and xylene when included in Schedule 6;

(b)in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of liquid hydrocarbons;

(c)in solid or semi-solid preparations;

(d)in preparations containing 25% or less of liquid hydrocarbons;

(e)in preparations packed in pressurised spray packs; or

(f)in adhesives packed in containers each containing 50 grams or less of adhesive

Hydrochloric Acid (excluding its salts and derivatives) in preparations containing 10% or less of hydrochloric acid (HC1), except—

(a)in preparations containing 0.5% or less of hydrochloric acid (HC1); or

(b)for therapeutic use

Hydrofluoric Acid and Hydrosilicofluoric Acid (excluding their salts and derivatives) in preparations containing 0.5% or less of hydrofluoric acid or hydrosilicofluoric acid, as the case may be

Hydrogen Peroxide (excluding its salts and derivatives), except in preparations containing 6% (20 vol) or less of hydrogen peroxide

Imazalil

Kerosene—see Hydrocarbons

Lead Compounds in preparations for use as hair cosmetics

Levamisole in preparations containing 15% or less of levamisole for the treatment of animals, except when included in Schedule 4

Lindane in preparations containing 10% or less of lindane, except when included in Schedule 2 or 4

Maldison in preparations containing 10% or less of maldison, except—

(a)when included in Schedule 2 or 4; or

(b)in dust preparations containing 2% or less of maldison

Mancozeb

Maneb

MCPA

MCPB

Mecoprop

Mepiquat

Metalaxyl

Metaldehyde in preparations containing 2% or less of metaldehyde

Methabenzthiazuron

Methanol (excluding its derivatives) in preparations containing 10% or less of methanol, except—

(a)in preparations containing 2% or less of methanol; or

(b)in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of methanol

Methazole

Methiocarb in pelleted preparations containing 2% or less of methiocarb

Methoxychlor

Methylated Spirits, being Methylated spirit, industrial, as defined by the Spirits Act 1906 (excluding its preparations and admixtures), except in containers having a capacity of more than 5 litres

Methylene Chloride—

(a)in pressurised spray packs in preparations that contain more than 10% of methylene chloride, when packed and labelled as degreasers, decarbonisers or paint strippers; and

(b)when not in pressurised spray packs

Methyl Ethyl Ketone, except—

(a)in preparations containing 25% or less of methyl ethyl ketone; or

(b)in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of methyl ethyl ketone

Methyl Ethyl Ketone Peroxide

Methyl Iso-amyl Ketone, except—

(a)in preparations containing 25% or less of methyl iso-amyl ketone; or

(b)in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of methyl iso-amyl ketone

Methyl Iso-butyl Ketone, except—

(a)in preparations containing 25% or less of methyl iso-butyl ketone; or

(b)in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of methyl iso-butyl ketone

Methyl Salicylate in liquid preparations containing 25% or more of methyl salicylate, except when included in Schedule 6

N-(3-Methyl-4-thiazolin-2-ylidene)-2,4-xylidene (Cymiazole)

Metiram

Metolachlor

Metribuzin

Mezineb

Mineral Turpentine—see Hydrocarbons

MSMA in herbicides or defoliant preparations containing 3% or less of arsenic

Myclobutanil

NAA, except in preparations containing 25% or less of NAA

Naled when impregnated in plastic resin strip material containing 20% or less of naled

Naphthalene as such

Naphthaleneacetic Acid—see NAA

Naptalam

Nitric Acid (excluding its salts and derivatives) in preparations containing 10% or less of nitric acid, except preparations containing 0.5% or less of nitric acid

Norbormide

Ofurace

Organo-tin Compounds—see Tin Organic Compounds

Oxadixyl

Oxycarboxin

Oxythioquinox

Paclobutrazol

Paradichlorobenzene

Pebulate

Penconazole

Pendimethalin

Peracetic Acid in concentrations of 10% or less or peracetic acid

Petrol, except—

(a)in preparations containing 25% or less of petrol; or

(b)in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of petrol

Phenisopham

Phenyl Methyl Ketone, except—

(a)in preparations containing 25% or less of phenyl methyl ketone; or

(b)in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of phenyl methyl ketone

ortho-Phenylphenol, except in preparations containing 5% or less of ortho-phenylphenol

Phosphonic Acid, except in preparations containing 10% or less of phosphonic acid

Phosphoric Acid (excluding its salts and derivatives), except—

(a)when packed in containers having a capacity of not less than 10 litres and labelled “CORROSIVE” in bold face sanserif capital letters of a height of not less than 1 cm;

(b)in preparations containing 350 g/litre or less of phosphoric acid;

(c)in solid and semi-solid preparations; or

(d)in professional dental kits

Pirimicarb in preparations containing 0.5% or less of pirimicarb

Poly (Hexamethylene Biguanide), except in preparations containing 5% or less of poly (hexamethylene biguanide)

Potassium Chlorate, except—

(a)when included in Schedule 2; or

(b)in preparations containing 10% or less of potassium chlorate

Potassium Hydroxide (excluding its salts and derivatives) in preparations containing 5% or less of potassium hydroxide, except in preparations containing 0.5% or less of potassium hydroxide

Potassium Sulphide in preparations for metal treatment in containers each containing 50 g or less of potassium suphide

Prometryn

Propamocarb

Propanil

Propiconazole in preparations containing 20% or less of propiconazole

Propionic Acid (excluding its salts and derivatives) in preparations containing 80% or less of propionic acid, except—

(a)in preparations containing 30% or less of propionic acid; or

(b)for therapeutic use

Propoxur—

(a)in dust preparations containing 3% or less of propoxur;

(b)in granular sugar-based fly baits containing 1% or less of propoxur provided the preparation also contains a dark colouring agent and a separate bittering agent;

(c)in aerosol packs containing 10 g or less of propoxur; or

(d)in printed paper sheets for pest control containing 0.5% or less of propoxur and in any case not more than 100 mg of propoxur per sheet

Pyrethrins, naturally occurring, being pyrethrolone, cinerolone or jasmolone esters of chrysanthemic or pyrethric acids, except in preparations containing 10% or less of such substances

Quaternary Ammonium Compounds in preparations containing more than 10% of quaternary ammonium compounds, except when included in another of these Schedules

Quintozene

Salicylanilide

Selenium Sulphide in preparations containing 2.5% or less of selenium sulphide for topical therapeutic use

Sethoxydim

Sodium Chlorate, except in preparations containing 10% or less of sodium chlorate

Sodium Hydrogen Sulphate, except in preparations containing 10% or less of sodium hydrogen sulphate

Sodium Hydroxide (excluding its salts and derivatives) in preparations containing 5% or less of sodium hydroxide, except in preparations containing 0.5% or less of sodium hydroxide

Sodium Hypochlorite, except in preparations containing 4% or less of available chlorine

Sodium Metabisulphite when packed for domestic use, except in preparations containing 10% or less of sodium metabisulphite

Sodium Nitrite, except—

(a)when included in Schedule 2; or

(b)in preparations containing 1% or less of sodium nitrite

Sodium Sulphide—

(a)in preparations for metal treatment in containers each containing 50 g or less of sodium sulphide; or

(b)in preparations for use as an insect lure

Styrene (excluding its derivatives), except in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of styrene

Sulfometuron-methyl

Sulphamic Acid, except in preparations containing 10% or less of sulphamic acid

2,3,6-TBA

TCA—see Trichloroacetic Acid

TDE in preparations containing 10% or less of TDE

Temephos—

(a)in liquid preparations containing 10% or less of temephos; or

(b)in powders containing 2% or less of temephos

Terbutryn

Tetrachloroethylene in preparations containing 5% or less of tetrachloroethylene, except—

(a)when prepared for therapeutic use;

(b)when absorbed into an inert solid; or

(c)in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of tetrachloroethylene

Tetrachlorvinphos, except in animal feed containing 0.2% or less of tetrachlorvinphos

Tetramethrin, except in pressurised spray packs

Thiobencarb

Tiocarbazil

Tolclofos-methyl

Tralkoxydim

Triadimefon in wettable powders containing 25% or less of triadimefon

Triadimenol

Tri-allate

Trichloroacetic Acid, alkali salts of

1,1,1-Trichloroethane, except—

(a)when included in Schedule 7;

(b)in preparations containing 25% or less of 1,1,1-trichloroethane;

(c)in packs containing 50 ml or less of 1,1,1-trichloroethane which are labelled—“WARNING—DO NOT DELIBERATELY SNIFF THIS PRODUCT. SNIFFING MIGHT HARM OR KILL YOU”;

(d)in aerosols other than for therapeutic use; or

(e)in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of 1,1,1-trichloroethane

Trichloroisocyanuric Acid in compressed block form for use in swimming pools or toilet cisterns

Tridiphane

Trietazine

Triflumizole

Turpentine Oil, except—

(a)in preparations containing 25% or less of turpentine oil; or

(b)in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of turpentine oil

Vernolate

Warfarin in rodent baits containing 0.1% or less of warfarin

Zineb

Ziram

SCHEDULE 6  Section 3

Acephate

Acetic Acid (excluding its salts and derivatives) in preparations containing more than 80% of acetic acid, except when included in Schedule 2

Acetic Anhydride (excluding its salts and derivatives) in preparations containing more than 80% of acetic anhydride, except for therapeutic use

Acifluorfen

Aldrin

Alphamethrin—see Cypermethrin

Amidithion

2-Amino-butane

Aminocarb in preparations containing 25% or less of aminocarb

Amitraz

Ammonia and Ammonium Hydroxide (excluding their salts and derivatives), except—

(a)when included in Schedule 5;

(b)in preparations for human internal therapeutic use;

(c)in preparations for inhalation when absorbed in an inert solid material; or

(d)in preparations containing 0.5% or less of free ammonia

Aniline (excluding its salts and derivatives), except in preparations containing 1% or less of aniline

Arecoline

Arsenic—

(a)in ant poisons containing 0.4% or less of arsenic;

(b)organic compounds of arsenic in herbicides or defoliant preparations, except when included in Schedule 5;

(c)in animal feed premixes containing 4% or less of arsenic;

(d)in preparations for the treatment of animals, except thiacetarsamide when included in Schedule 4; or

(e)in paints containing more than 0.1% of arsenic when calculated on the basis of the non-volatile content of the paint;

except when separately specified in this Schedule

Avermectin B1 in preparations containing 1% or less of avermectin B1, for the treatment of animals, when supplied in sealed containers for use in automatic injection equipment

Azaconazole, except in preparations containing 1% or less of azaconazole

Azobenzene

Bacitracin in animal feed premixes for growth promotion containing 2% or less of antibiotic substances

Barium salts, except—

(a)when included in Schedule 5;

(b)barium sulphate; or

(c)barium metaborate in paint

Bendiocarb—

(a)in wettable powders containing 80% or less of bendiocarb, when packed in containers or primary packs containing not less than 100g of bendiocarb;

(b)in wettable powders containing 20% or less of bendiocarb and not less than 0.002% of denatonium benzoate, when packed in containers or primary packs containing not less than 48 g of bendiocarb and labelled for use as a fly control preparation; or

(c)in insoluble granular preparations containing 5% or less of bendiocarb;

except when included in Schedule 5

Benomyl

Benquinox

Bensulide

5-Benzylfur-3-ylmethyl(1'R,3'S.E)-2',2'-dimethyl-3'-(2-oxo-2,3,4,5-tetrahydro-3- thienylidenemethyl)-cyclopropane Carboxylate

Benzylpenicillin (including procaine penicillin) in preparations for intramammary infusion in animals containing not more than 100 000 I.U. per dose of benzylpenicillin or procaine penicillin, when suitably coloured with Brilliant Blue FCF or other approved colour as a marker, and when packed in applicator devices specially designed for the purpose

Beryllium

BHC (excluding the γ-isomer), except when included in Schedule 5

Bithionol for treatment of animals

Brodifacoum in preparations containing 0.25% or less of brodifacoum

Bromadiolone in preparations containing 0.25% or less of bromadiolone

Bromoform, except when included in Schedule 4

Bromophos

Bromophos-ethyl

Bromoxynil

Brotianide

Bunamidine

Butacarb

Butoxycarboxim, except when included in Schedule 5

2-Butoxy-2'-thiocyano-diethyl Ether

Butynorate

Cacodylic Acid in animal feed premixes containing 4% or less of arsenic

Cadmium compounds, except when included in Schedule 5

Cajuput Oil, except in oils or preparations containing 25% or less of cineole

Calciferol in rodent baits

Cambendazole

Carbaryl, except when included in Schedule 2, 4 or 5

Carbendazim

Carbon Disulphide

α-Chloralose—see Chloralose

Chloralose (α-Chloralose) when packed and labelled for use as a pesticide

Chlordane

Chlorfenethol

Chlormequat

N-[5-Chloro-4-[(4-chlorophenyl)-cyanomethyl]-2-methylphenyl]-2-hydroxy-3,5-diiodobenzamide

Chloroform, except—

(a)when included in Schedule 2 or 4; or

(b)in preparations containing 10% or less of chloroform

α-Chlorohydrin

Chlorophacinone

Chloropicrin in preparations containing 5% of less of chloropicrin

Chlorothalonil

Chlorpyrifos, except when included in Schedule 5

Chlorpyrifos-methyl

Chlortetracycline in preparations—

(a)for topical application to animals for ocular use only; or

(b)for intramammary infusion in animals containing not more than 100,000 I.U. per dose of chlortetracycline, when suitably coloured with Brilliant Blue FCF or other approved colour as a marker, and when packed in applicator devices specially designed for the purpose

Chlorthiamid

Cholecalciferol in rodent baits containing 1 g/kg or less of cholecalciferol

Chromates and Dichromates

Chromium Trioxide, excluding its salts and derivatives

Cineole, except in oils or preparations containing 25% or less of cineole

Climbazole, except—

(a)when included in Schedule 5; or

(b)in preparations containing 2% or less of climbazole

Clotrimazole for external treatment of animals

Coumaphos in preparations containing 5% or less of coumaphos

Coumatetralyl

Creosote, except—

(a)when included in Schedule 2; or

(b)in preparations containing 3% or less of phenols and homologues of phenol boiling below 220ºC

Crotoxyphos

Crufomate

Cyanamide

Cyanazine

Cyfluthrin, except—

(a)when included in Schedule 5; or

(b)in pressurised spray packs containing 1% or less of cyfluthrin

Cyometrinil

Cypermethrin, except when included in Schedule 5

Cythioate

Dazomet

DDT and its preparations, except—

(a)when included in Schedule 5; or

(b)dicophane included in Schedule 2

Deltamethrin in aqueous formulation containing 1% or less of deltamethrin, when no other organic solvent, other than a glycol, is present

Demeton-O-methyl in preparations containing 10% or less of demeton-O-methyl, or of demeton-O-methyl and demeton-S-methyl

Demeton-S-methyl in preparations containing 10% or less of demeton-S-methyl, or of demeton-S-methyl and demeton-O-methyl

Diazinon, except when included in Schedule 5

Dichlofenthion

ortho-Dichlorobenzene

Dichloroethyl Ether

1,2-Dichloropropane

Dichlorvos in preparations containing 50% or less of dichlorvos, except when included in Schedule 5

Diclofop-methyl

Dicophane—see DDT

Dieldrin

Diethylene Dioxide

Difenacoum in preparations containing 0.25% or less of difenacoum

Difenzoquat

Dihydrostreptomycin in preparations for intramammary infusion in animals containing not more than 100 000 I.U. per dose of dihydrostreptomycin, when suitably coloured with Brilliant Blue FCF or other approved colour as a marker, and when packed in applicator devices specially designed for the purpose

Dimethipin

Dimethoate

1,3-Di(methoxycarbonyl)-1-propen-2-yl-dimethyl Phosphate in preparations containing 25% or less of 1,3-di(methoxycarbonyl)-1-propen-2-yl-dimethyl phosphate

Dimethylformamide, except—

(a)when included in Schedule 5; or

(b)in containers having a capacity of more than 25 litres which are labelled “WARNING” and state the proportion of dimethylformamide

Dimethyl sulphoxide—

(a)when not for therapeutic use; or

(b)for the treatment of animals—

(i)when combined with no other therapeutic substance; or

(ii)in preparations containing copper salicyclate as the only other therapeutic substance

Dimetilan in preparations containing 25% or less of dimetilan

Dinitrocresols and their homologues, in preparations containing 5% or less of such compounds, except—

(a)when included in Schedule 4; or

(b)when separately specified in this Schedule

Dinotrophenols and their homologues, in preparations containing 5% or less of such compounds, except—

(a)when included in Schedule 4; or

(b)when separately specified in this Schedule

Dinocap

Dioxacarb

Diphacinone

Diquat

Disulfiram, except when included in Schedule 4

Disulfoton in granular preparations containing 5% or less of disulfoton

Dithianon

Dithiazanine in preparations containing 2% or less of dithiazanine, for the treatment of animals

Dithiocarbamates when prepared for agricultural, horticultural or pastoral purposes, except—

(a)when included in Schedule 5; or

(b)when separately specified in this Schedule

Diuredosan

DSMA in herbicides or defoliant preparations, except when included in Schedule 5

Econazole for the external treatment of animals

Endosulfan

Endothal

Erythromycin—

(a)in preparations for intramammary infusion in animals containing not more than 100 000 I.U. per dose of erythromycin, when suitably coloured with Brilliant Blue FCF or other approved colour as a marker, and when packed in applicator devices specially designed for the purpose; or

(b)in animal feed premixes for growth promotion containing 2% or less of antibiotic substances

Esfenvalerate

Ether, except—

(a)when included in Schedule 2, 4 or 5; or

(b)in preparations containing 10% or less of ether

Ethiofencarb

Ethoate-methyl

Ethoprophos in granular formulations containing 10% or less of ethoprophos and 2% of linseed oil

Ethyl Bromide

Ethyl-2-[4-(6-chloro-2-quinoxalyloxy)phenoxy] propionate (Quizalofop Ethyl)

Ethylene Chlorohydrin

Ethylene Dichloride

Ethylene Glycol when packed and labelled as a boiling point or freezing point modifier, except when included in Schedule 5

Ethylene Glycol Monoalkyl Ethers and their Acetates, except—

(a)in preparations containing 10% or less of such substances; or

(b)in containers having a capacity of 25 litres or more which are labelled “POISON”, and with the name and quantity of the ether, the name of the manufacturer or the trade mark and the statement “Avoid contact with skin and eyes and avoid breathing the vapour”

Etridiazole

Etrimfos

Eucalyptus Oil, except in preparations containing 25% or less of eucalyptus oil

Famphur in preparations containing 20% or less of famphur

Fenaminosulf in preparations containing 10% or less of fenaminosulf when labelled and packed as dry seed dressings

Fenamiphos in granular preparations containing 5% or less of fenamiphos

Fenazaflor

Fenbutatin-oxide

Fenchlorphos

Fenitrothion

Fenoxacarim in preparations for the treatment of carpets during manufacture

Fenthion, except when included in Schedule 5

Fenvalerate

Ferbam

Flavophospholipol in animal feed premixes for growth promotion containing 2% or less of antibiotic substances

Fluazifop-butyl

Fluazifop-p-butyl

Flucofuron in preparations for the treatment of carpets during manufacture

Flumethrin, except when included in Schedule 5

Fluorides and Silicofluorides, except—

(a)when included in Schedule 2, 3, 4 or 5;

(b)in preparations containing 3% or less of sodium fluoride or sodium silicofluoride as preservative;

(c)in pesticide preparations containing 3.2% or less of ammonium fluosilicate;

(d)in dentifrices containing 1000 mg/kg or less of fluoride ion; or

(e)in preparations containing 15 mg/kg or less of fluoride ion

Flupropanate

Flusilazol

Flutriafol, except in fertilizers containing 0.5% or less of flutriafol

Fluvalinate, except when included in Schedule 5

Formaldehyde (excluding its derivatives), except in preparations containing 5% or less of formaldehyde

Formothion

Fospirate, except when included in Schedule 5

Fumagillin

Glutaraldehyde, except when included in Schedule 2 or 5

Guazatine

Haloxon

Haloxyfop

Heptachlor

Hexachlorophane in preparations for the treatment of animals

Hydramethylnone, except when included in Schedule 5

Hydrazine

Hydrochloric Acid (excluding its salts and derivatives), except in preparations containing 10% or less of hydrochloric acid (HC1)

Hydrofluoric Acid and Hydrosilicofluoric Acid (excluding their salts and derivatives) in preparations containing 10% or less of hydrofluoric acid or hydrosilicofluoric acid, as the case may be, except when included in Schedule 5

Hydroquinone, except—

(a)when included in Schedule 2 or 4; or

(b)in preparations containing 10% or less of hydroquinone

Hydrosilicofluoric Acid—see Hydrofluoric Acid

Hygromycin for use as an anthelmintic in animal feed premixes containing 2% or less of antibiotic substances

Imidocarb

Iodine (excluding its salts, derivatives and iodophors), except—

(a)when included in Schedule 2; or

(b)in solid or semi-solid preparations containing 2.5% or less of available iodine

Iodophors and cadexomer iodine, except in preparations containing 1.5% or less of available iodine

Ioxynil

Iron Compounds for the treatment of animals, except—

(a)in liquid or gel preparations containing 0.1% or less of iron; or

(b)in animal feeds and feed premixes

Isoconazole for the external treatment of animals

Isocyanates, free organic, except in paints containing 0.1% or less of free organic isocyanates

Ivermectin in preparations containing 0.8 g/L of ivermectin for the treatment of sheep

Kitasamycin in animal feed premixes for growth promotion containing 2% or less of antibiotic substances

Lasalocid, except in animal feeds containing 100 mg/kg or less of antibiotic substances

Laurylisoqinolinium Bromide

Lead Compounds, except—

(a)when included in Schedule 4 or 5;

(b)in preparations for cosmetic use containing 100 mg/kg or less of lead; or

(c)in pencil cores, finger colours, showcard colours, pastels, crayons, poster paints, poster colours or coloured chalks when these products contain 100 mg/kg or less of lead

Levamisole for the treatment of animals, except—

(a)when included in Schedule 4 or 5; or

(b)in preparations containing 10 mg or less of levamisole for the treatment of ornamental birds or ornamental fish

Lindane, except when included in Schedule 2, 4 or 5

Maduramicin in animal feed premixes containing 1% or less of antibiotic substances

Mafenide for the treatment of aquarium fish

Maldison, except—

(a)when included in Schedule 2, 4 or 5; or

(b)in dust preparations containing 2% or less of maldison

Mebendazole for the treatment of animals

Meclofenamic Acid for the treatment of animals

Mefluidide

Melaleuca Oil (Ti-tree Oil), except in oils or preparations containing 25% or less of cineole

Menazon

Mercuric Iodide when prepared for agricultural, horticultural, pastoral or industrial use

Mercuric Thiocyanate when prepared for use for photographic purposes

Mercurous Chloride, except when included in Schedule 4

Mercury (metallic), except—

(a)when included in Schedule 4; or

(b)in scientific instruments

Mercury organic compounds in preparations for agricultural, horticultural or pastoral use, except ethoxyethylmercuric chloride and ethylmercuric chloride in Schedule 7

Metacresolsulphonic Acid and Formaldehyde Condensation Product for the treatment of animals

Metaldehyde, except when included in Schedule 5

Metham

Methanol (excluding its derivatives), except—

(a)when included in Schedule 5; or

(b)in preparations containing 2% or less of methanol

Methiocarb, except when included in Schedule 5

Methomyl in fly-baits containing 1% or less of methomyl and not less than 0.002% of denatonium benzoate as a bittering agent

Methyl Chloride

Methylenebisthiocyanate, except in preparations containing 1% or less of methylenebisthiocyanate

Methyl Isothiocyanate

Methyl Salicylate, excluding admixtures

Miconazole for the external treatment of animals

Molinate

Monensin—

(a)in animal feed premixes for growth promotion or for coccidiosis prevention containing 12.5% or less of monensin; or

(b)in intraruminal implants for cattle each containing 35g or less of monensin

MSMA in herbicides or defoliant preparations, except when included in Schedule 5

Nabam—see Dithiocarbamates

Naled, except when included in Schedule 5

Nalidixic Acid when packed and labelled for the treatment of ornamental fish

Naphthalophos when specifically prepared and packed for use as a sheep drench

Narasin in animal feed premixes containing 120 g/kg or less of narasin

Neomycin in preparations for topical application to animals for ocular use only

Nicotine in preparations containing 3% or less of nicotine, when packed and labelled for the treatment of animals

Nimidane in preparations containing 25% or less of nimidane

Nithiamide, except in preparations containing 20% or less of nithiamide

Nitric Acid (excluding its salts and derivatives), except in preparations containing 10% or less of nitric acid as such

Nitrobenzene, except—

(a)in solid or semi-solid polishes;

(b)in soaps containing 1% or less of nitrobenzene; or

(c)in preparations containing 0.1% or less of nitrobenzene

Nitrophenols, ortho, meta and para

Nitroscanate

Nitroxynil

Novobiocin in preparations for intramammary infusion in animals containing not more than 100 000 I.U. per dose of novobiocin, when suitably coloured with Brilliant Blue FCF or other approved colour as a marker, and when packed in applicator devices specially designed for the purpose

Octhilinone—see 2-Octyl-4-isothiazolin-3-one

2-Octyl-4-isothiazolin-3-one

Oestradiol-17-β-

(a)in ear implants for growth promotion in bovine cattle; or

(b)in combination with progesterone, testosterone or trenbolone in ear implants for growth promotion in bovine cattle

Olaquindox in animal feed premixes for growth promotion

Oleandomycin in animal feed premixes for growth promotion containing 2% or less of antibiotic substances

Omethoate in preparations containing 50% or less of omethoate

Organo-tin Compounds—see Tin Organic Compounds

Oxadiazon

Oxalic Acid, except its derivatives and insoluble salts

Oxantel Embonate for the treatment of animals

Oxfendazole

Oxyclozanide

Oxytetracycline in preparations—

(a)for topical application to animals for ocular use only; or

(b)for intramammary infusion in animals containing not more than 100 000 I.U. per dose of oxytetracycline, when suitably coloured with Brilliant Blue FCF or other approved colour as a marker, and when packed in applicator devices specially designed for the purpose

Parbendazole

Pentachlorophenol, except in preparations containing 0.5 % or less of pentachlorophenol

Peracetic Acid, except when included in Schedule 5

Perfluidone

Permanganates

Phenethicillin in preparations for intramammary infusion in animals containing not more than 100 000 I.U. per dose of phenethicillin, when suitably coloured with Brilliant Blue FCF or other approved colour as a marker, and when packed in applicator devices specially designed for the purpose

Phenkapton in preparations containing 50% or less of phenkapton

Phenol and any homologue of phenol boiling below 220ºC, except—

(a)when included in Schedule 2; or

(b)in preparations containing 3% or less by weight of such substances

Phenothiazine (excluding its derivatives), except in preparations containing 10% or less of phenothiazine

Phenoxymethylpenicillin in preparations for intramammary infusion in animals containing not more than 100 000 I.U. per dose of phenoxymethylpenicillin, when suitably coloured with Brilliant Blue FCF or other approved colour as a marker, and when packed in applicator devices specially designed for the purpose

Phenylenediamines and alkylated phenylenediamines not elsewhere specified in this Schedule or in Schedule 2—

(a)when used in hair dyes;

(b)in preparations packed and labelled for photographic purposes; or

(c)in preparations packed and labelled for testing water, except diethyl- or dimethyl-para-phenylenediamine in tablets containing 10 mg or less of phenylenediamine in opaque strip packaging labelled—

“FOR WATER TESTING. DO NOT DISCARD TESTING SOLUTIONS INTO POOL”

Phosalone

Phosmet

Phosphides, Metallic

Phosphorus, Yellow (excluding its salts and derivatives) in preparations containing 0.5% or less of free phosphorus

Phoxim

Picric Acid (excluding its derivatives), except in preparations containing 5% or less of picric acid

Pindone

Piperophos

Pirimicarb, except when included in Schedule 5

Pirimiphas-ethyl

Pirimiphas-methyl

Potassium Bromate, except in preparations containing 0.5% or less of potassium bromate

Potassium Cyanate

Potassium Hydroxide (excluding its salts and derivatives), except—

(a)when included in Schedule 5; or

(b)in preparations containing 0.5% or less of potassium hydroxide

Prochloraz

Profenofos

Progesterone—

(a)in a silicone rubber elastomer when used as a controlled-release implant for synchronisation of oestrus in cattle; or

(b)in combination with oestradiol-17-β or trenbolone, in ear implants for growth promotion in bovine cattle

Promacyl

Promecarb in preparations containing 50% or less of promecarb

Propachlor

Propargite

Propetamphos

Propiconazole, except when included in Schedule 5

Propionic Acid (excluding its salts and derivatives), except—

(a)when included in Schedule 5;

(b)in preparations containing 30% or less of propionic acid; or

(c)for therapeutic use

Propoxur, except when included in Schedule 4 or 5

Propylene Oxide in preparations containing 4% or less of propylene oxide

Prothiofos

Pyrazophos

Rafoxanide

Salinomycin in animal feed premixes containing 6% or less of antibiotic substances

Selenium Compounds—

(a)in preparations containing 2.5% or less of selenium—

(i)when packed and labelled for the blueing of gun barrels; or

(ii)when packed and labelled for photographic purposes;

(b)in coated granules containing 1% or less of selenium for application to pasture;

(c)as a drench, injection, paste, stock lick or vaccine containing 0.5% or less of selenium for the treatment of animals;

(d)in premixes containing 2% or less of selenium when packed and labelled for incorporation into animal feeds to provide 0.1 g/tonne or less of selenium; or

(e)in tablets each weighing 2 grams or more and each containing 30 micrograms or less of selenium for incorporation into animal feeds

Silver Nitrate, except—

(a)when included in Schedule 2; or

(b)in chewing tablets

Sodium Bromate, except in preparations containing 0.5% or less of sodium bromate

Sodium Hydroxide (excluding its salts and derivatives), except—

(a)when included in Schedule 5; or

(b)in preparations containing 0.5% or less of sodium hydroxide

Spiramycin in animal feed premixes for growth promotion containing 2% or less of antibiotic substances

Streptomycin in preparations for intramammary infusion in animals containing not more than 100 000 I.U. per dose of streptomycin, when suitably coloured with Brilliant Blue FCF or other approved colour as a marker, and when packed in applicator devices specially designed for the purpose

Strychnine in grain baits containing 0.5% or less of strychnine

Sulcofuron in preparations for the treatment of carpets during manufacture

Sulphanilamide and its derivatives when packed and labelled for the treatment of ornamental caged birds or ornamental fish

Sulphaquinoxaline when packed and labelled for use as a coccidiostat in poultry, except preparations containing 200 mg/kg or less of sulphaquinoxaline

Sulphuric Acid (excluding its salts and derivatives), except—

(a)in fire extinguishers; or

(b)in preparations containing 0.5% or less of sulphuric acid

Sulprophos

2,4,5-T

TCA—see Trichloroacetic Acid

TCMTB (2-[thiocyanomethylthio]benzothiazole)

TDE, except when included in Schedule 5

Temephos, except when included in Schedule 5

Terbuthylazine

Terpenes, Chlorinated

Testosterone—

(a)testosterone cypionate, dipropionate, enanthate and propionate in preparations labelled for treatment and prevention of pizzle (sheath) rot in wethers;

(b)in preparations labelled for masculinisation of wethers for use as 'teaser rams' to stimulate and detect reproductive activity in ewes;

(c)in combination with oestradiol-17-β or trenbolone in ear implants for growth promotion in bovine cattle; or

(d)in oil preparations for growth promotion purposes labelled for injection at the base of the ear in sheep

Tetrachloroethylene, except—

(a)when included in Schedule 5;

(b)in preparations containing 6% or less of tetrachloroethylene when absorbed into an inert solid;

(c)when prepared for use for the treatment of humans or for the treatment of animals; or

(d)in containers having a capacity of more than 25 litres which are labelled “POISON” and state the proportion of tetrachloroethylene

Tetracycline in preparations—

(a)for topical application to animals for ocular use only;

(b)for intramammary infusion in animals containing not more than 100 000 I.U. per dose of tetracycline, when suitably coloured with Brilliant Blue FCF or other approved colour as a marker, and when packed in applicator devices specially designed for the purpose; or

(c)when packed and labelled for treatment of ornamental caged birds or ornamental fish only

Tetradifon

2,2',6,6'-Tetraisopropyl-diphenyl-carbodiimide in amitraz formulations containing 2% or less of 2,2',6,6'-tetraisopropyl-1-diphenyl-carbodiimide

Tetramisole in preparations for the treatment of animals

Thiazafluron

Thiodicarb

Thiometon

Thiourea and alkyl thioureas, except for therapeutic use

Thiram

Tiamulin for the treatment of animals—

(a)in feed premixes containing 25% or less of tiamulin; or

(b)in soluble concentrates containing 45% or less of tiamulin

Tin Organic Compounds, being di-alkyl, tri-alkyl and tri-phenyl tin compounds where the alkyl group is methyl, ethyl, propyl or butyl, except—

(a)when separately specified in this Schedule; or

(b)in plastics

Ti-tree Oil—see Melaleuca Oil

Toluene (excluding its derivatives), except—

(a)in preparations containing 50% or less of toluene or toluene and xylene; or

(b)in containers having a capacity of more than 25 litres which are labelled “POISON” and state the proportion of toluene or toluene and xylene

Trenbolone—

(a)in ear implants for growth promotion in bovine cattle; or

(b)in combination with oestradiol-17-β, progesterone or testosterone in ear implants for growth promotion in bovine cattle

Triadimefon, except—

(a)when included in Schedule 5; or

(b)in fertilizers containing 5 g/kg or less of triadimefon

S,S,S-Tributylphosphorothioate

Trichlorfon

Trichloroacetic Acid, except when included in Schedule 5

Trichloroethylene, except—

(a)when included in Schedule 4; or

(b)for other human therapeutic use

Trichlorophenol

Triclopyr

Tridemorph

Triethyl Phosphate

Trifluoromethane Sulphonic Acid

Tylosin in animal feed premixes for growth promotion containing 5% or less of antibiotic substances

Vamidothion

Virginiamycin in animal feed premixes for growth promotion containing 2% or less of antibotic substances

Warfarin, except—

(a)when included in Schedule 4 or 5; or

(b)for external therapeutic use

Xylene (excluding its derivatives), except—

(a)in preparations containing 50% or less of xylene or xylene and toluene; or

(b)in containers having a capacity of more than 25 litres which are labelled “POISON” and state the proportion of xylene or xylene and toluene

Zeranol in ear implants for use as a growth promotant in steer cattle

Zinc Chloride, except in preparations containing 5% or less of zinc chloride

Zinc p-Phenolsulphonate, except in preparations containing 5% or less of zinc p-phenolsulphonate

Zinc Sulphate, except—

(a)when included in Schedule 4;

(b)in preparations for human internal use with a recommended daily dose of 50 mg or less of zinc; or

(c)in other preparations containing 5% or less of zinc sulphate

SCHEDULE 7  Section 3

Acrolein

Acrylonitrile

Alachlor

Aldicarb

Aldoxycarb

Allyl Alcohol

Aminocarb, except when included in Schedule 6

4-Aminopyridine, except when included in Schedule 4

Amiton

ANTU

Aromatic Extract Oils, being aromatic hydrocarbons boiling in whole or in part above 300ºC, except when incorporated into solid polymers of either natural or synthetic origin or in fuel oils

Arprinocid

Arsenic, except—

(a)thiacetarsamide when included in Schedule 4;

(b)when included in Schedule 5 or 6;

(c)selenium arsenide in photocopier drums; or

(d)in animal feeds containing 75 g/tonne or less of arsenic

Avermectin B1, except when included in Schedule 6

Azinphos-ethyl

Azinphos-methyl

Azocyclotin

Bendiocarb, except when included in Schedule 5 or 6

Benzene (excluding its derivatives), except—

(a)preparations containing 15 ml/L or less of benzene; or

(b)petrol containing 50 ml/L or less of benzene

Betahydroxyethylhydrazine

Binapacryl

Bithionol, except when included in Schedule 6

Brodifacoum, except when included in Schedule 6

Bromadiolone, except when included in Schedule 6

Calamus for human therapeutic use

Calciferol for use as a rodenticide, except when included in Schedule 6

Camphechlor

Captafol

Captan

Carbadox

Carbofuran

Carbon Tetrachloride

Carbophenothion

Chlordecone

Chlordimeform

Chlorfenvinphos

Chlorine, excluding its salts and derivatives

Chloromethiuron

5-Chloro-3-methyl-4-nitropyrazole

4-Chloro-o-toluidine

Chloropicrin, except when included in Schedule 6

Chlorthiophos

Cholecalciferol for use as a rodenticide, except when included in Schedule 6

Clioquinol and other halogenated 8-hydroxyquinoline derivatives, for internal human use

Coumaphos, except when included in Schedule 6

Cyanides—see Hydrocyanic Acid

Cyhalothrin

Cyhexatin

Deltamethrin, except when included in Schedule 6

Demeton

Demeton-O-methyl, except when included in Schedule 6

Demeton-S-methyl, except when included in Schedule 6

Dialifos

4,4-Diaminodiphenylmethane

1,2-Dibromo-3-chloropropane

1,3-Dichloropropene

Dichlorvos, except when included in Schedule 5 or 6

Dicrotophos

Dienochlor

Difenacoum, except when included in Schedule 6

Dimefox

1,3-Di(methoxycarbonyl)-1-propen-2-yl-dimethyl Phosphate, except when included in Schedule 6

N,N-Dimethyl-4-(phenylazo)-benzamine

Dimethyl Sulphate

Dimetilan, except when included in Schedule 6

Dinitrocresols, except when included in Schedule 4 or 6

Dinitrophenols, except when included in Schedule 4 or 6

Dinoseb

Disulfoton, except when included in Schedule 6

Endrin

Epichlorohydrin

Etaconazole

Ethion

Ethoprophos, except when included in Schedule 6

Ethoxyethylmercuric Chloride

Ethylene Dibromide

Ethylene Oxide

Ethylmercuric Chloride

Famphur, except when included in Schedule 6

Fenaminosulf, except when included in Schedule 6

Fenamiphos, except when included in Schedule 6

Fenoxacarim, except—

(a)when included in Schedule 6; or

(b)in treated carpets

Fensulfothion

Fenthion-ethyl

Flucofuron, except—

(a)when included in Schedule 6; or

(b)in treated carpets

Flucythrinate

Flunixin Meglumine, except when included in Schedule 4

Fluoroacetamide

Fluoroacetic Acid

Folpet

Formetanate

Halofuginone, except in prepared stockfeeds containing 3 g/tonne or less of halofuginone

Halogenated Dibenzodioxins and Dibenzofurans

Hexachlorobenzene

Hydrocyanic Acid and Cyanides, except—

(a)when included in Schedule 1 or 2; or

(b)ferrocyanides and ferricyanides

Hydrofluoric Acid and Hydrosilicofluoric Acid (excluding their salts and derivatives), except when included in Schedule 5 or 6

Isocarbophos

Isofenphos

Ivermectin, except when included in Schedule 6

Leptophos

Maduramicin, except when included in Schedule 6

Mazidox

Mecarbam

Mercuric Chloride when prepared for use for agricultural, industrial, pastoral or horticultural purposes

Methacrifos

Methamidophos

Methapyrilene

Methidathion

Methomyl, except when included in Schedule 6

Methyl Bromide

Mevinphos

Mipafox

Mirex

Monocrotophos

Naphthalophos, except when included in Schedule 6

Nicotine, except—

(a)when included in Schedule 3, 4 or 6; or

(b)in tobacco prepared and packed for smoking

Nimidane, except when included in Schedule 6

Nitrofen

Omethoate, except when included in Schedule 6

Oxamyl

Oxyfluorfen

Paraquat

Parathion

Parathion-methyl

Phenkapton, except when included in Schedule 6

Phorate

Phosfolan

Polychlorinated Biphenyls

Promecarb, except when included in Schedule 6

Propylene Oxide, except when included in Schedule 6

Pyrinuron

Schradan

Strychnine, except—

(a)Nux vomica included in Schedule 1; or

(b)when included in Schedule 4 or 6

Sulcofuron, except—

(a)when included in Schedule 6; or

(b)in treated carpets

Sulfotep

TEPP

Terbufos

Tetrachloroethane

2,2',6,6'-Tetraisopropyl-diphenyl-carbodiimide, except when included in Schedule 6

Thallium

Thiofanox

ortho-Tolidine

Toxaphene—see Camphechlor

Triamiphos

Triazbutil

1,1,1-Trichloroethane in aerosols for therapeutic use

Trichloroisocyanuric Acid, except—

(a)when included in Schedule 5; or

(b)in preparations containing 4% or less of available chlorine

Vinyl Chloride

SCHEDULE 8  Section 3

Acetyldihydrocodeine, except when included in Schedule 4

Acetylmethadol

Acetylmorphines

Alfentanil

Allylprodine

Alphacetylmethadol

Alphameprodine

Alphamethadol

Alphaprodine

Amphetamine

Amylobarbitone, except when included in Schedule 4

Anileridine

Benzethidine

Benzylmorphine

Betacetylmethadol

Betameprodine

Betamethadol

Betaprodine

Bezitramide

Butobarbitone

Butorphanol

Clonitazene

Cocaine

Coca Leaf

Codeine, except when included in Schedule 2, 3, or 4

Codeine-N-oxide

Codoxime

Concentrate of Poppy Straw (the material arising when poppy straw has entered into a process for concentration of its alkaloids)

4-Cyano-2-dimethylamino-4, 4-diphenylbutane (Methadone intermediate)

4-Cyano-1-methyl-4-phenylpiperidine (Pethidine intermediate A)

Cyclobarbitone

Dexamphetamine

Dextromoramide

Dextropropoxyphene, except when included in Schedule 4

Diampromide

Diethylthiambutene

Difenoxin, except when included in Schedule 4

Dihydrocodeine, except when included in Schedule 2, 3 or 4

Dihydromorphine

Dimenoxadol

Dimepheptanol

Dimethylthiambutene

Dioxaphetyl Butyrate

Diphenoxylate, except when included in Schedule 4

Dipipanone

Drotebanol

Ecgonine and its esters or derivatives which are convertible to ecgonine and cocaine

Ethylmethylthiambutene

Ethylmorphine, except when included in Schedule 2 or 4

Etonitazene

Etoxeridine

Fenetylline

Fentanyl

Furethidine

Hydrocodone

Hydromorphinol

Hydromorphone

Hydroxypethidine

Isomethadone

Levamphetamine

Levomethamphetamine

Levomethorphan

Levomoramide

Levophenacylmorphan

Levorphanol

Mecloqualone

Metazocine

Methadone

Methamphetamine

Methyldesorphine

Methyldihydromorphine

2-Methyl-3-morpholino-1, 1-diphenylpropane Carboxylic Acid (Moramide intermediate)

Methylphenidate

1-Methyl-4-phenylpiperidine-4-carboxylic Acid (Pethidine intermediate C)

Metopon

Morpheridine

Morphine

Morphine Methobromide

Morphine-N-oxide

Myrophine

Nabilone

Nicocodine, except when included in Schedule 4

Nicodicodine, except when included in Schedule 4

Nicomorphine

Noracymethadol

Norcodeine, except when included in Schedule 4

Norlevorphanol

Normethadone

Normorphine

Norpipanone

Opium in any form, except the alkaloids noscapine and papaverine

Oxycodone

Oxymorphone

Pentazocine

Pentobarbitone, except when included in Schedule 4

Pethidine

Phenadoxone

Phenampromide

Phenazocine

Phenmetrazine

Phenomorphan

Phenoperidine

4-Phenylpiperidine-4-carboxylic Acid Ethyl Ester (Pethidine intermediate B)

Pholcodine, except when included in Schedule 2 or 4

Piminodine

Piritramide

Proheptazine

Properidine

Propiram

Quinalbarbitone

Racemethorphan

Racemoramide

Racemorphan

Secbutobarbitone

Sufentanil

Thebacon

Thebaine

Tilidine

Trimeperidine

SCHEDULE 12  Section 3

Acetorphine

Acetyl-α-methylfentanyl

Alkoxyamphetamines and bromo-substituted alkoxyamphetamines, except when separately specified in this Schedule

Alkoxyphenethylamines and alkyl-substituted alkoxyphenethylamines, except when separately specified in this Schedule

2-Amino-1-(2,5-dimethoxy-4-methyl) phenylpropane (STP, DOM)

4-Bromo-3,5-dimethoxyamphetamine

4-Bromo-2,5-dimethoxyphenethylamine (BDMPEA)

3-Bromo-4-methoxyamphetamine

4-Bromo-3-methoxyamphetamine

Bufotenine

Cannabis

Cannabis Oil

Cannabis Resin

Cathinone

Desomorphine

N,N-Diethyltryptamine (DET)

2,4-Dimethoxyamphetamine

3,4-Dimethoxyamphetamine

2,-5-Dimethoxy-4-bromoamphetamine (DOB)

3,4-Dimethoxy-5-ethoxyamphetamine

2,5-Dimethoxy-4-ethoxyamphetamine

4,5-Dimethoxy-2-ethoxyamphetamine

2,5-Dimethoxy-4-ethyl-α-methylphenylethylamine (DOET)

2,3-Dimethoxy-4,5-methylenedioxyamphetamine

2,5-Dimethoxy-3,4-methylenedioxyamphetamine

2,5-Dimethoxy-α-methylphenylethylamine (DMA)

3,4-Dimethoxyphenylethylamine

3-(2-Dimethylaminoethyl)-4-hydroxyindole (Psilocine, Psilotsin)

3-(1,2-Dimethylheptyl)-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran (DMHP)

N,N-Dimethyltryptamine (DMT)

4,5-Ethylenedioxy-3-methoxyamphetamine

Eticyclidine (PCE)

Etorphine

Harmaline

Harmine

Heroin

3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran (Parahexyl)

β-Hydroxyfentanyl

β-Hydroxy-3-methylfentanyl

Ketobemidone

Lysergic Acid

Lysergide (LSD, LSD-25)

Mescaline—see 3,4,5-Trimethoxyphenethylamine

Methaqualone

2-Methoxy-3,4-methylenedioxyamphetamine

2-Methoxy-4,5-methylenedioxyamphetamine

4-Methoxy-2,3-methylenedioxyamphetamine

5-Methoxy-3,4-methylenedioxy-α-methylphenylethylamine (MMDA)

2-Methoxy-3,4-methylenedioxyphenylethylamine

3-Methoxy-4,5-methylenedioxyphenylethylamine

4-Methoxy-α-methylphenylethylamine (PMA)

4-Methoxyphenylethylamine

3,4-Methylenedioxyamphetamine (MDA)

3,4-Methylenedioxy-N, α-dimethylphenylethylamine (MDMA)

3,4-Methylenedioxy-N-ethylamphetamine (MDE)

α-Methylfentanyl

3-Methylfentanyl

1-Methyl-4-phenyl-4-propionoxypiperidine (MPPP)

α-Methylthiofentanyl

3-Methylthiofentanyl

Muscimol

Para-fluorofentanyl

Phencyclidine (PCP)

1-Phenylethyl-4-phenyl-4-acetoxypiperidine (PEPAP)

Psilocine—see 3-(2-Dimethylaminoethyl)-4-hydroxyindole

Psilocybine

Psilotsin—see 3-(2-Dimethylaminoethyl)-4-hydroxyindole

Rolicyclidine (PHP, PCPY)

Tenocyclidine (TCP)

Tetrahydrocannabinols (THC) and their alkyl homologues, except when separately specified in this Schedule

2,3,4,5-Tetramethoxyamphetamine

Thiofentanyl

2,3,4-Trimethoxyamphetamine

2,3,5-Trimethoxyamphetamine

2,3,6-Trimethoxyamphetamine

2,4,5-Trimethoxyamphetamine

2,4,6-Trimethoxyamphetamine

3,4,5-Trimethoxy-α-methylphenylethylamine (TMA)

3,4,5-Trimethoxyphenethylamine (Mescaline) and other substances structurally derived from methoxy-phenylethylamine, except—

(a)methoxyphenamine; or

(b)when separately specified in this Schedule

1-(3,4,5-Trimethoxyphenyl)-2-aminobutane

2,4,5-Trimethoxyphenylethylamine

NOTES

1. Notified in the Commonwealth of Australia Gazette on 20 December 1988.

2. No. 38, 1978 as amended by Nos. 19 and 56, 1981; No. 47, 1982; No. 67, 1985; Nos. 32 and 76, 1986; No. 29, 1988.